<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotics for acute otitis media in children - Venekamp, RP - 2023 | Cochrane Library</title> <meta content="Antibiotics for acute otitis media in children - Venekamp, RP - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000219.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotics for acute otitis media in children - Venekamp, RP - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000219.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000219.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotics for acute otitis media in children" name="citation_title"/> <meta content="Roderick P Venekamp" name="citation_author"/> <meta content="University Medical Center Utrecht, Utrecht University" name="citation_author_institution"/> <meta content="r.p.venekamp@umcutrecht.nl" name="citation_author_email"/> <meta content="Sharon L Sanders" name="citation_author"/> <meta content="Bond University" name="citation_author_institution"/> <meta content="Paul P Glasziou" name="citation_author"/> <meta content="Bond University" name="citation_author_institution"/> <meta content="Maroeska M Rovers" name="citation_author"/> <meta content="Radboud University Nijmegen Medical Centre" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD000219.pub5" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/11/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000219.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000219.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000219.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Anti-Bacterial Agents [adverse effects]; Diarrhea [chemically induced]; *Exanthema; *Otitis Media [drug therapy, epidemiology]; Pain [drug therapy]; *Tympanic Membrane Perforation [chemically induced, drug therapy]; Vomiting [chemically induced]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000219.pub5&amp;doi=10.1002/14651858.CD000219.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="jU9oKp1Y";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000219\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000219\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ko","pt","ms","hr","fr","zh_HANS","zh_HANT","th","fa","id","pl","nl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000219.pub5",title:"Antibiotics for acute otitis media in children",firstPublishedDate:"Nov 15, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000219.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000219.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000219.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000219.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000219.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000219.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;nl&quot;,&quot;title&quot;:&quot;Samenvatting in eenvoudige taal&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000219.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000219.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000219.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000219.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8086 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000219.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-sec-0122"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-sec-0116"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/appendices#CD000219-sec-0127"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/supinfo/CD000219-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/supinfo/CD000219-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotics for acute otitis media in children</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information#CD000219-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Roderick P Venekamp</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information#CD000219-cr-0005">Sharon L Sanders</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information#CD000219-cr-0006">Paul P Glasziou</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information#CD000219-cr-0007">Maroeska M Rovers</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information/en#CD000219-sec-0175">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 November 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000219.pub5">https://doi.org/10.1002/14651858.CD000219.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000219-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000219-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000219-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000219-abs-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000219-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000219-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD000219-abs-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000219-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000219-abs-0001" lang="en"> <section id="CD000219-sec-0001"> <h3 class="title" id="CD000219-sec-0001">Background</h3> <p>Acute otitis media (AOM) is one of the most common diseases in childhood for which antibiotics are commonly prescribed; a systematic review reported a pooled prevalence of 85.6% in high‐income countries. This is an update of a Cochrane Review first published in the Cochrane Library in 1997 and updated in 1999, 2005, 2009, 2013 and 2015. </p> </section> <section id="CD000219-sec-0002"> <h3 class="title" id="CD000219-sec-0002">Objectives</h3> <p>To assess the effects of antibiotics for children with AOM.</p> </section> <section id="CD000219-sec-0003"> <h3 class="title" id="CD000219-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, Current Contents, CINAHL, LILACS and two trial registers. The date of the search was 14 February 2023. </p> </section> <section id="CD000219-sec-0004"> <h3 class="title" id="CD000219-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials comparing 1) antimicrobial drugs with placebo, and 2) immediate antibiotic treatment with expectant observation (including delayed antibiotic prescribing) in children with AOM. </p> </section> <section id="CD000219-sec-0005"> <h3 class="title" id="CD000219-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened trials for inclusion and extracted data using the standard methodological procedures recommended by Cochrane. Our primary outcomes were: 1) pain at various time points (24 hours, two to three days, four to seven days, 10 to 14 days), and 2) adverse effects likely to be related to the use of antibiotics. Secondary outcomes were: 1) abnormal tympanometry findings, 2) tympanic membrane perforation, 3) contralateral otitis (in unilateral cases), 4) AOM recurrences, 5) serious complications related to AOM and 6) long‐term effects (including the number of parent‐reported AOM symptom episodes, antibiotic prescriptions and health care utilisation as assessed at least one year after randomisation). We used the GRADE approach to rate the overall certainty of evidence for each outcome of interest. </p> </section> <section id="CD000219-sec-0006"> <h3 class="title" id="CD000219-sec-0006">Main results</h3> <p><b>Antibiotics versus placebo</b> </p> <p>We included 13 trials (3401 children and 3938 AOM episodes) from high‐income countries, which we assessed at generally low risk of bias. </p> <p>Antibiotics do not reduce pain at 24 hours (risk ratio (RR) 0.89, 95% confidence interval (CI) 0.78 to 1.01; 5 trials, 1394 children; high‐certainty evidence), or at four to seven days (RR 0.76, 95% CI 0.50 to 1.14; 7 trials, 1264 children), but result in almost a third fewer children having pain at two to three days (RR 0.71, 95% CI 0.58 to 0.88; number needed to treat for an additional beneficial outcome (NNTB) 20; 7 trials, 2320 children; high‐certainty evidence), and likely result in two‐thirds fewer having pain at 10 to 12 days (RR 0.33, 95% CI 0.17 to 0.66; NNTB 7; 1 trial, 278 children; moderate‐certainty evidence). Antibiotics increase the risk of adverse events such as vomiting, diarrhoea or rash (RR 1.38, 95% CI 1.16 to 1.63; number needed to treat for an additional harmful outcome (NNTH) 14; 8 trials, 2107 children; high‐certainty evidence). </p> <p>Antibiotics reduce the risk of children having abnormal tympanometry findings at two to four weeks (RR 0.83, 95% CI 0.72 to 0.96; NNTB 11; 7 trials, 2138 children), slightly reduce the risk of experiencing tympanic membrane perforations (RR 0.43, 95% CI 0.21 to 0.89; NNTB 33; 5 trials, 1075 children) and halve the risk of contralateral otitis episodes (RR 0.49, 95% CI 0.25 to 0.95; NNTB 11; 4 trials, 906 children). However, antibiotics do not reduce the risk of abnormal tympanometry findings at six to eight weeks (RR 0.89, 95% CI 0.70 to 1.13; 3 trials, 953 children) and at three months (RR 0.94, 95% CI 0.66 to 1.34; 3 trials, 809 children) or late AOM recurrences (RR 0.94, 95% CI 0.79 to 1.11; 6 trials, 2200 children). Severe complications were rare, and the evidence suggests that serious complications do not differ between children treated with either antibiotics or placebo. </p> <p><b>Immediate antibiotics versus expectant observation</b> </p> <p>We included six trials (1556 children) from high‐income countries.</p> <p>The evidence suggests that immediate antibiotics may result in a reduction of pain at two to three days (RR 0.53, 95% CI 0.35 to 0.79; NNTB 8; 1 trial, 396 children; low‐certainty evidence), but probably do not reduce the risk of pain at three to seven days (RR 0.75, 95% CI 0.50 to 1.12; 4 trials, 959 children; moderate‐certainty evidence), and may not reduce the risk of pain at 11 to 14 days (RR 0.91, 95% CI 0.75 to 1.10; 1 trial, 247 children; low‐certainty evidence). Immediate antibiotics increase the risk of vomiting, diarrhoea or rash (RR 1.87, 95% CI 1.39 to 2.51; NNTH 10; 3 trials, 946 children; high‐certainty evidence). </p> <p>Immediate antibiotics probably do not reduce the proportion of children with abnormal tympanometry findings at four weeks and evidence suggests that immediate antibiotics may not reduce the risk of tympanic membrane perforation and AOM recurrences. No serious complications occurred in either group. </p> </section> <section id="CD000219-sec-0007"> <h3 class="title" id="CD000219-sec-0007">Authors' conclusions</h3> <p>This review reveals that antibiotics probably have no effect on pain at 24 hours, a slight effect on pain in the days following and only a modest effect on the number of children with tympanic perforations, contralateral otitis episodes and abnormal tympanometry findings at two to four weeks compared with placebo in children with AOM. In high‐income countries, most cases of AOM spontaneously remit without complications. The benefits of antibiotics must be weighed against the possible harms: for every 14 children treated with antibiotics, one child experienced an adverse event (such as vomiting, diarrhoea or rash) that would not have occurred if antibiotics were withheld. </p> <p>For most children with mild disease in high‐income countries, an expectant observational approach seems justified. Therefore, clinical management should emphasise advice about adequate analgesia and the limited role for antibiotics. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000219-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000219-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD000219-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD000219-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000219-abs-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000219-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD000219-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/id#CD000219-abs-0021">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000219-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000219-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/nl#CD000219-abs-0023">Nederlands</a> </li> <li class="section-language"> <a class="" href="full/pl#CD000219-abs-0022">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD000219-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD000219-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD000219-abs-0018">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000219-abs-0015">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD000219-abs-0016">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000219-abs-0002" lang="en"> <h3>Antibiotics for acute middle ear infection (acute otitis media) in children</h3> <p><b>Key messages</b><br/>In high‐income countries, most children with acute otitis media (AOM) recover spontaneously without complications, and compared with placebo antibiotics have no early effect on pain and only a slight effect on pain in the days following. </p> <p>Any benefits of antibiotics must be weighed against the possible harms: for every 14 children treated with antibiotics one child experienced an adverse event (such as vomiting, diarrhoea or rash) that would not have occurred if antibiotics were not given. </p> <p>For most children with mild disease in high‐income countries, an expectant observational approach seems justified. </p> <p><b>What is AOM?</b><br/>AOM or acute middle ear infection is one of the most common diseases in early infancy and childhood, causing pain and general symptoms of illness such as fever, irritability and problems feeding and sleeping. </p> <p><b>What did we want to find out?</b><br/>We wanted to find out if antibiotics are effective for relieving signs and symptoms in children with AOM. </p> <p><b>What did we do?</b><br/>We searched for studies that looked at the effectiveness of antibiotics compared with placebo or expectant observation (watchful waiting) in children aged from one month to 15 years with AOM. We compared and summarised their results, and rated our confidence in the evidence, based on factors such as study methods and effect sizes. </p> <p><b>What did we find?</b><br/>We found that antibiotics did not decrease the number of children with pain at 24 hours (when 60% of children recovered or improved), only slightly reduced the number of children with pain in the days following, and did not reduce the number of children with late AOM recurrences compared with placebo. However, antibiotics did slightly reduce the number of children with perforations (a rupture) of the eardrum and AOM in the initially unaffected ear compared with placebo. Antibiotics reduced the number of children with abnormal tympanometry (a test to evaluate how well the middle ear is functioning) findings at two to four weeks but not after six to eight weeks and three months. </p> <p>There was not enough information to know if antibiotics reduced rare complications such as mastoiditis (infection of the bones around the ear). All the studies included in this review were from high‐income countries. Data are lacking from populations in which the AOM incidence and risk of progression to mastoiditis is higher. </p> <p>Antibiotics caused unwanted effects such as diarrhoea, vomiting and rash. It is difficult to balance the small benefits against the small harms of antibiotics in children with AOM. However, for most children with mild disease in high‐income countries, an expectant observational approach seems justified. </p> <p><b>What are the limitations of the evidence?</b><br/>From the review of antibiotics against placebo, we are confident that antibiotics have no effect on pain in the first 24 hours and only a slight effect in the days following. We are only moderately confident that antibiotics reduce pain experienced 10 to 12 days after children are initially assessed. Our confidence is moderate because only one study reported this result from a secondary analysis. We are confident that antibiotics modestly reduce the number of children with abnormal tympanometry results after two to four weeks, but that they do not reduce the risk at three months. We are confident that antibiotics increase the risk of unwanted effects. </p> <p>For the review of immediate antibiotics versus expectant observation, we have little confidence that immediate antibiotics reduce pain two to three days after assessment and are moderately confident that immediate antibiotics probably do not reduce pain at three to seven days. Our confidence is limited because of concerns about how some of the studies were conducted. </p> <p><b>How up‐to‐date is this evidence?</b><br/>Our evidence is current to 14 February 2023. The findings of this update are consistent with previous versions of the review. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000219-sec-0122" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000219-sec-0122"></div> <h3 class="title" id="CD000219-sec-0123">Implications for practice</h3> <section id="CD000219-sec-0123"> <p>Antibiotics produce a (small) reduction in the number of children with pain at two to three days (number needed to treat with antibiotics for an additional beneficial outcome (NNTB) 20) and 10 to 12 days (NNTB 7) from initial assessment, and reduce the number of children with tympanic membrane perforations (NNTB 33), contralateral otitis episodes (NNTB 11) and abnormal tympanometry findings at two to four weeks (NNTB 11) compared with placebo. However, in high‐income countries, most cases of acute otitis media (AOM) spontaneously remit without complications. The benefits of antibiotics must be weighed against the possible harms: for every 14 children treated with antibiotics one child experienced an adverse event (such as vomiting, diarrhoea or rash) that would not have occurred if antibiotics were withheld. Therefore, management should emphasise advice about adequate analgesia and the limited role for antibiotics. Based on a separate individual participant data meta‐analysis performed in 2006, using data from six trials (1643 children), which were also included in this review as individual trials, antibiotics are most useful in children under two years of age with bilateral AOM, or with both AOM and otorrhoea (<a href="./references#CD000219-bbs2-0058" title="RoversMM , GlasziouP , AppelmanCL , BurkeP , McCormickDP , DamoiseauxRA , et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet2006;368:1429-35.">Rovers 2006</a>). For most other children with mild disease, an expectant observational approach seems justified. </p> </section> <h3 class="title" id="CD000219-sec-0124">Implications for research</h3> <section id="CD000219-sec-0124"> <p>Further research is needed to determine if it is possible to predict which children are more likely to suffer from the complications of AOM and whether an expectant observation approach can be safely applied to children with mild AOM in low‐income countries. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000219-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000219-sec-0008"></div> <div class="table" id="CD000219-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Antibiotics versus placebo for acute otitis media in children</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Antibiotics versus placebo for acute otitis media in children</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> children with acute otitis media<br/><b>Settings:</b> primary care and secondary care<br/><b>Intervention:</b> antibiotics versus placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Antibiotics versus placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ pain at 24 hours</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>426 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>379 per 1000</b><br/>(332 to 431) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.89</b> <br/>(0.78 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1394<br/>(5 studies)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ pain at 2 to 3 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>159 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>113 per 1000</b><br/>(92 to 140) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.71</b> <br/>(0.58 to 0.88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2320<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ pain at 4 to 7 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>248 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>189 per 1000</b><br/>(124 to 283) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.76</b> <br/>(0.50 to 1.14) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1264<br/>(7 studies)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ pain at 10 to 12 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>216 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1000</b><br/>(37 to 142) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.33</b> <br/>(0.17 to 0.66) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>278<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vomiting, diarrhoea or rash</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>196 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>270 per 1000</b><br/>(227 to 319) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.38</b> <br/>(1.16 to 1.63) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2107<br/>(8 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Abnormal tympanometry ‐ 2 to 4 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>481 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>399 per 1000</b><br/>(347 to 462) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> <br/>(0.72 to 0.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2138<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Abnormal tympanometry ‐ 3 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>241 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>227 per 1000</b><br/>(159 to 323) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> <br/>(0.66 to 1.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>809<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> for ‘Study population’ was the average risk in the control groups (i.e. total number of participants with events divided by total number of participants included in the meta‐analysis). The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The number of studies reported in the summary of findings table for the outcomes 'Pain at 24 hours' and 'Pain at 4 to 7 days' differs slightly from those reported in the Data and Analysis Table 1 ‐ Antibiotics versus placebo (five versus six studies and seven versus eight studies, respectively). This is due to the van Buchem trial. This trial is included as one study in our review (and in the summary of findings table), but we included data from two different comparisons from this 2 x 2 factorial design trial (<a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>) in our analyses.<br/><sup>b</sup>We downgraded the evidence for pain at days 10 to 12 from high certainty due to inconsistency. Only one trial reported this outcome and the outcome was not specified a priori. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000219-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Immediate antibiotics versus expectant observation for acute otitis media in children</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Immediate antibiotics versus expectant observation for acute otitis media in children</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> children with acute otitis media<br/><b>Settings:</b> primary care and secondary care<br/><b>Intervention:</b> immediate antibiotics versus expectant observation </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Antibiotics versus expectant observation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ Pain at 2 to 3 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>284 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b><br/>(99 to 224) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.53</b><br/>(0.35 to 0.79) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ Pain at 3 to 7 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>356 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>267 per 1000</b><br/>(178 to 398) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.75</b><br/>(0.50 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>959<br/>(4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ Pain at 11 to 14 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>669 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>609 per 1000</b><br/>(502 to 736) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b><br/>(0.75 to 1.10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>247<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vomiting, diarrhoea or rash</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>114 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>214 per 1000</b><br/>(159 to 287) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.87</b><br/>(1.39 to 2.51) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>946<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Abnormal tympanometry at 4 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>495 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>510 per 1000</b><br/>(386 to 668) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.03</b><br/>(0.78 to 1.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>207<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> for ‘Study population’ was the average risk in the control groups (i.e. total number of participants with events divided by total number of participants included in the meta‐analysis). The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the evidence for pain at two to three days from high certainty due study limitations (risk of detection bias) and imprecision (outcome data derived from one trial).<br/><sup>b</sup>We downgraded the evidence for pain at three to seven days from high certainty due study limitations (risk of detection bias).<br/><sup>c</sup>We downgraded the evidence for pain at days 11 to 14 from high certainty due study limitations (risk of detection bias) and because of the number of children that were 'lost to follow‐up' (13%), which introduced a risk of (attrition) bias.<br/><sup>d</sup>We downgraded the evidence for abnormal tympanometry findings at four weeks from high certainty as the number of children that were 'lost to follow‐up' in the immediate antibiotics group was substantially lower than in the expectant observation group (4% versus 11%), thereby introducing a risk of (attrition) bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000219-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000219-sec-0009"></div> <section id="CD000219-sec-0010"> <h3 class="title" id="CD000219-sec-0010">Description of the condition</h3> <p>Despite reports of a decline during the COVID‐19 pandemic (<a href="./references#CD000219-bbs2-0045" title="Gisselsson-SolenM , HermanssonA . Trends in upper respiratory tract infections and antibiotic prescriptions during the COVID-19 pandemic - a national observational study. Acta Otolaryngology2022;142(7-8):549-52.">Gisselsson‐Solen 2022</a>; <a href="./references#CD000219-bbs2-0049" title="HullegieS , SchilderAG , MarchisioP , deSévauxJL , van derVeldenAW , vande PolAC , et al. A strong decline in the incidence of childhood otitis media during the COVID-19 pandemic in the Netherlands. Frontiers in Cellular and Infection Microbiology2021;11:768377. [DOI: 10.3389/fcimb.2021.768377]">Hullegie 2021</a>), acute otitis media (AOM) is one of the most frequent diseases in early infancy and childhood. AOM is defined as the presence of middle ear effusion and a rapid onset of signs or symptoms of middle ear inflammation, such as ear pain, otorrhoea or fever (<a href="./references#CD000219-bbs2-0033" title="American Academy of Pediatrics and American Academy of Family Physicians. Clinical practice guidelines: diagnosis and management of acute otitis media. Pediatrics2013;131(3):e964-99.">AAP 2013</a>). Approximately 10% of children have an episode of AOM by three months of age and, by three years of age, approximately 50% to 85% of all children have experienced at least one AOM episode (<a href="./references#CD000219-bbs2-0062" title="TeeleDW , KleinJO , RosnerB . Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. Journal of Infectious Diseases1989;160(1):83-94.">Teele 1989</a>). The peak incidence is within the first year of life (<a href="./references#CD000219-bbs2-0055" title="MonastaL , RonfaniL , MarchettiF , MonticoM , BrumattiLV , BavcarA , et al. Burden of disease caused by otitis media: systematic review and global estimates. PLOS One2012;7(4):e36226.">Monasta 2012</a>). </p> </section> <section id="CD000219-sec-0011"> <h3 class="title" id="CD000219-sec-0011">Description of the intervention</h3> <p>Despite a large number of published clinical trials, there is no consensus regarding the most appropriate therapy for AOM; a recent systematic review reported a pooled prevalence of antibiotic prescribing rates in ambulatory care of 85.6% for this condition in high‐income countries (<a href="./references#CD000219-bbs2-0038" title="BurvenichR , DillenH , TrinhNT , FreerJ , WynantsL , HeytensS , et al. Antibiotic use in ambulatory care for acutely ill children in high-income countries: a systematic review and meta-analysis. Archives of Disease in Childhood2022;107(12):1088-94.">Burvenich 2022</a>). One meta‐analysis emphasises that AOM resolves spontaneously in most children (<a href="./references#CD000219-bbs2-0056" title="RosenfeldRM , VertreesJE , CarrJ , CipolleRJ , UdenDL , GiebinkGS , et al. Clinical efficacy of antimicrobial drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials. Journal of Pediatrics1994;124:355-67.">Rosenfeld 1994</a>). However, one semi‐randomised trial of 1365 participants conducted in Sweden in 1954 reported a rate of mastoiditis of 17% in the untreated group versus none in the penicillin‐treated groups (<a href="./references#CD000219-bbs2-0027" title="RudbergRD . Acute otitis media: comparative therapeutic results of sulphonamide and penicillin administered in various forms. Acta Oto-Laryngologica1954;113(Suppl):1-79. ">Rudberg 1954</a>). Over recent years, prescription strategies in which antibiotic treatment for acute respiratory infections such as AOM is delayed and instituted only if symptoms persist or worsen after several days have been advocated (<a href="./references#CD000219-bbs2-0033" title="American Academy of Pediatrics and American Academy of Family Physicians. Clinical practice guidelines: diagnosis and management of acute otitis media. Pediatrics2013;131(3):e964-99.">AAP 2013</a>). </p> </section> <section id="CD000219-sec-0012"> <h3 class="title" id="CD000219-sec-0012">How the intervention might work</h3> <p>AOM has a multifactorial pathogenesis. Mucosal swelling of the nasopharynx and Eustachian tube due to a viral upper respiratory tract infection can lead to Eustachian tube dysfunction with impaired clearance and pressure regulation of the middle ear. Prolonged dysfunction may be followed by aspiration of potential viral and bacterial pathogens from the nasopharynx to the middle ear. These pathogens might in turn provoke a host inflammatory response, which leads to the clinical manifestations of AOM such as ear pain, otorrhoea, fever and irritability. <i>Streptococcus pneumoniae</i> (<i>S pneumoniae</i> ) has been the predominant pathogen related to AOM for many years, next to <i>Moraxella catarrhalis</i> (<i>M catarrhalis</i> ) and non‐typeable <i>Haemophilus influenzae</i> (<i>H influenzae</i> ). However, recent studies suggest that widespread implementation of pneumococcal conjugate vaccination has changed the frequency of otopathogens related to AOM with non‐typeable <i>H influenzae</i> and non‐vaccine <i>S pneumoniae</i> serotypes becoming more prevalent (<a href="./references#CD000219-bbs2-0039" title="CaseyJR , KaurR , FriedelVC , PichicheroME . Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatic Infectious Disease Journal2013;32(8):805-9.">Casey 2013</a>; <a href="./references#CD000219-bbs2-0042" title="CokerTR , ChanLS , NewberrySJ , LimbosMA , SuttorpMJ , ShekellePG , et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA2010;304(19):2161-9.">Coker 2010</a>)<i>.</i> Additionally, viral (co‐)infection is known to worsen the clinical and bacteriological outcome of AOM (<a href="./references#CD000219-bbs2-0035" title="ArolaM , RuuskanenO , ZieglerT , MertsolaJ , Näntö-SalonenK , Putto-LaurilaA , et al. Clinical role of respiratory virus infection in acute otitis media. Pediatrics1990;86:848-55.">Arola 1990</a>; <a href="./references#CD000219-bbs2-0041" title="ChonmaitreeT , OwenMJ , PatelJA , HedgpethD , HorlickD , HowieVM . Effect of viral respiratory tract infection on outcome of acute otitis media. Journal of Pediatrics1992;120:856-62.">Chonmaitree 1992</a>). As bacteria are considered to play a predominant role in the causation of AOM‐related symptoms, antibiotic treatment may accelerate clinical recovery and may reduce the number of complications related to AOM. </p> </section> <section id="CD000219-sec-0013"> <h3 class="title" id="CD000219-sec-0013">Why it is important to do this review</h3> <p>Although numerous randomised clinical trials (RCTs) on the effectiveness of antibiotic treatment in children with AOM have been performed over the decades, consensus regarding the most appropriate treatment strategy is lacking. As symptoms consistent with AOM resolve spontaneously in most children, an expectant observational approach might be justified. We therefore performed a systematic review to examine the effects of both immediate antibiotic treatment and an expectant observational approach in children with AOM. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000219-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000219-sec-0014"></div> <p>To assess the effects of antibiotics for children with AOM.</p> <p>We attempted to determine to what extent antibiotic therapy was more effective than placebo and what, if any, advantages it offered to children in terms of symptom relief (pain), avoidance of complications (such as tympanic membrane perforations and severe complications such as mastoiditis) and longer‐term hearing problems from middle ear effusion (as measured by tympanometry or audiometry). We also assessed the effect of immediate antibiotics versus expectant observation on AOM. Moreover, we aimed to provide information on subgroups of children with AOM that benefit more from antibiotics than others. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000219-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000219-sec-0015"></div> <section id="CD000219-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000219-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) of antimicrobial drugs versus placebo control. We also included RCTs comparing immediate antibiotics versus expectant observation. We did not include quasi‐RCTs, cross‐over trials or cluster‐randomised trials. </p> </section> <section id="CD000219-sec-0018"> <h4 class="title">Types of participants</h4> <p>Studies including children (aged from one month to 15 years) of either gender without ventilation tubes, suffering from AOM irrespective of the setting from which they were recruited. </p> </section> <section id="CD000219-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Antimicrobial drugs versus placebo control.</p> <p>Immediate antibiotic versus expectant observation (also known as 'wait and see' or 'watchful waiting' or 'observation therapy'). This includes expectant observational approaches in which prescriptions may or may not be provided. </p> </section> <section id="CD000219-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We focused our data extraction on patient‐relevant outcomes, that is, those symptoms or problems that are important to the patient's sense of well‐being. While other endpoints, such as microbiological cure, may enhance medical understanding of the disease process, decisions about treatment should focus on helping the patient. We analysed the outcomes listed below in this review, but these outcomes were not used as a basis for including or excluding studies. </p> <section id="CD000219-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD000219-list-0001"> <li> <p>Proportion of children with pain at various time points (24 hours, two to three days, four to seven days, 10 to 14 days). </p> </li> <li> <p>Adverse effects likely to be related to the use of antibiotics such as vomiting, diarrhoea or rash. </p> </li> </ol> </p> </section> <section id="CD000219-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD000219-list-0002"> <li> <p>Abnormal tympanometry findings at various time points (two to four weeks, six to eight weeks, and three months) as a surrogate measure for hearing problems caused by middle ear fluid. Tympanometry is an acoustic evaluation of middle ear function. </p> </li> <li> <p>Tympanic membrane perforation.</p> </li> <li> <p>Contralateral otitis (in unilateral cases).</p> </li> <li> <p>AOM recurrences.</p> </li> <li> <p>Serious complications related to AOM such as mastoiditis and meningitis.</p> </li> <li> <p>Long‐term effects (including the number of parent‐reported AOM symptom episodes, antibiotic prescriptions and health care utilisation as assessed at least one year after randomisation). </p> </li> </ol> </p> </section> </section> </section> <section id="CD000219-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>We conducted systematic searches for RCTs and controlled clinical trials. There were no language, publication year or publication status restrictions. We searched up to 14 February 2023. </p> <section id="CD000219-sec-0024"> <h4 class="title">Electronic searches</h4> <p>For this update we searched the Cochrane Central Register of Controlled Trials (CENTRAL 2023, Issue 2) (February 2023), which contains the Acute Respiratory Infections (ARI) Specialised Register; MEDLINE (OVID; April 2015 to February week 2, 2023); Embase (OVID; April 2015 to 2023 Week 06); Current Contents Connect (Web of Science, 2015 to February 2023); CINAHL (EBSCOHost, April 2015 to February 2023) and LILACS (BIREME, 2015 to February 2023). Our previous update using the same search strategies covered the period 2008 to April 2015. See <a href="./appendices#CD000219-sec-0128">Appendix 1</a> for details of earlier searches. </p> <p>We used the search strategy described in <a href="./appendices#CD000219-sec-0130">Appendix 2</a> to search CENTRAL and MEDLINE. We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision); Ovid format (<a href="./references#CD000219-bbs2-0052" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Lefebvre 2021</a>). We adapted the search strategy to search Embase (<a href="./appendices#CD000219-sec-0131">Appendix 3</a>), Current Contents (<a href="./appendices#CD000219-sec-0132">Appendix 4</a>), CINAHL (<a href="./appendices#CD000219-sec-0133">Appendix 5</a>) and LILACS (<a href="./appendices#CD000219-sec-0134">Appendix 6</a>). </p> </section> <section id="CD000219-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We checked the World Health Organization International Clinical Trials Registry Platform (WHOICTRP; <a href="https://trialsearch.who.int/Default.aspx" target="_blank">trialsearch.who.int</a>) and ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>) for ongoing trials (14 February 2023) using the terms: antibiotics and Otitis Media and Child*. </p> <p>To increase the yield of relevant studies, we inspected the reference lists of all identified studies and reviews. </p> </section> </section> <section id="CD000219-sec-0026"> <h3 class="title" id="CD000219-sec-0026">Data collection and analysis</h3> <section id="CD000219-sec-0027"> <h4 class="title">Selection of studies</h4> <p>One review author (RPV) screened titles and abstracts obtained from the database searches. Two review authors (RPV, SLS) reviewed the full text of the potentially relevant titles and abstracts against the inclusion criteria. We resolved any disagreements by discussion. </p> </section> <section id="CD000219-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (RPV, SLS) extracted data from the included studies. We resolved disagreements by discussion. </p> </section> <section id="CD000219-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (RPV, SLS) independently assessed the methodological quality of the included trials. We resolved any disagreements by discussion. We assessed the methodological quality of the included studies as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000219-bbs2-0047" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>): </p> <p> <ul id="CD000219-list-0003"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting; and</p> </li> <li> <p>other sources of bias.</p> </li> </ul> </p> <p>We used the Cochrane risk of bias tool to assign a judgement about the adequacy of each domain: 'low', 'high' or 'unclear' risk of bias. Results of the 'Risk of bias' assessment are presented in a risk of bias summary (<a href="#CD000219-fig-0001">Figure 1</a>) and a risk of bias graph (<a href="#CD000219-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD000219-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000219-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD000219-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000219-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> </section> <section id="CD000219-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We expressed dichotomous outcomes as risk ratio (RR) and risk difference (RD) with 95% confidence intervals (CIs). Additionally, we calculated the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH) (1/(absolute risk in exposed minus absolute risk in unexposed)). </p> </section> <section id="CD000219-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We did not identify any studies with non‐standard designs, such as cross‐over trials and cluster‐randomised trials. </p> </section> <section id="CD000219-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We tried to contact the trial authors to provide additional information in case of missing data. </p> </section> <section id="CD000219-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the level of clinical heterogeneity between the trials by reviewing differences across trials in study population, setting, intervention and outcome measures used. In the absence of substantial clinical heterogeneity, we performed meta‐analyses. We used the Chi<sup>2</sup> test (with a significance level set at P &lt; 0.10), and the I<sup>2</sup> statistic (with I<sup>2</sup> values over 50%, suggesting substantial heterogeneity) to assess statistical heterogeneity. For the outcome of pain, we explored the magnitude of baseline risk and heterogeneity using L'Abbé plots (a graph of the proportion of participants with an outcome by the proportion of participants without an outcome) (<a href="./references#CD000219-bbs2-0060" title="SongF . Exploring heterogeneity in meta-analysis: is the L'Abbé plot useful?Journal of Clinical Epidemiology1999;52(8):725-30.">Song 1999</a>). </p> </section> <section id="CD000219-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed reporting bias as outcome reporting bias and publication bias.</p> <p>We assessed outcome reporting bias by comparing the outcomes reported in the published report against the study protocol or trial registry, whenever this could be obtained. If there was insufficient information to judge the risk of bias we noted this as an 'unclear' risk of bias (<a href="./references#CD000219-bbs2-0047" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). </p> <p>If we were able to pool 10 or more studies in a single analysis, we planned to produce a funnel plot to explore possible publication bias. In the absence of bias the plot should approximately resemble a symmetrical (inverted) funnel (<a href="./references#CD000219-bbs2-0048" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). </p> </section> <section id="CD000219-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We analysed the data according to the intention‐to‐treat (ITT) principle, whereby all participants are analysed in the groups to which they were randomly allocated. We performed meta‐analysis where we judged clinical heterogeneity to be minimal, to ensure that we would derive clinically meaningful results. We calculated treatment differences by the Mantel‐Haenszel method using a random‐effects model. We presented results separately for the reviews of antibiotics against placebo and immediate antibiotics versus expectant observation. </p> </section> <section id="CD000219-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not perform subgroup analyses.</p> </section> <section id="CD000219-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We did not perform sensitivity analyses.</p> </section> <section id="CD000219-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>For each prespecified outcome, we used the GRADE approach to rate the certainty of the body of evidence as it relates to the studies that contribute data to the meta‐analyses (<a href="./references#CD000219-bbs2-0046" title="GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), accessed 1 September 2023. Available at gradepro.org.">GRADEpro GDT</a>). There are four possible ratings: high, moderate, low and very low. The GRADE approach rates evidence from RCTs that do not have serious limitations as high certainty. However, several factors can lead to the downgrading of the evidence. The degree of downgrading is determined by the seriousness of these factors: study limitations, consistency of effect, imprecision, indirectness and publication bias. We used the methods and recommendations described in Chapter 14 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000219-bbs2-0048" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). We justified all decisions to downgrade the certainty of studies using footnotes, and we made comments to aid the reader's understanding of the review where necessary. </p> <p>We downgraded the certainty of evidence to moderate, low or very low depending on the presence of each of the following factors: </p> <p> <ol id="CD000219-list-0004"> <li> <p>study limitations (risk of bias);</p> </li> <li> <p>indirectness of evidence (directness of evidence);</p> </li> <li> <p>imprecision (precision of results);</p> </li> <li> <p>inconsistency (consistency of results); and</p> </li> <li> <p>publication bias (existence of publication bias).</p> </li> </ol> </p> <p>We included <a href="./full#CD000219-tbl-0001">summary of findings Table 1</a> for the review of antibiotics against placebo and <a href="./full#CD000219-tbl-0002">summary of findings Table 2</a> for the review of immediate antibiotics versus expectant observation. We included our primary outcomes and important secondary outcomes in the summary of findings tables: </p> <p> <ol id="CD000219-list-0005"> <li> <p>pain at 24 hours;</p> </li> <li> <p>pain at two to three days;</p> </li> <li> <p>pain at four to seven days;</p> </li> <li> <p>pain at 10 to 12 days;</p> </li> <li> <p>adverse effects likely to be related to the use of antibiotics (vomiting, diarrhoea or rash); </p> </li> <li> <p>abnormal tympanometry findings at two to four weeks; and</p> </li> <li> <p>abnormal tympanometry findings at three months.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000219-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000219-sec-0039"></div> <section id="CD000219-sec-0040"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD000219-sec-0181" title="">Characteristics of included studies</a>, <a href="./references#CD000219-sec-0182" title="">Characteristics of excluded studies</a> and <a href="./references#CD000219-sec-0183" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD000219-sec-0041"> <h4 class="title">Results of the search</h4> <p>This is an update of a Cochrane Review first published in the Cochrane Library in Issue 1, 1997 (<a href="./references#CD000219-bbs2-0064" title="GlasziouPP , HayemM , Del MarCB . Treatments for acute otitis media in children: antibiotic versus placebo. Cochrane Database of Systematic Reviews1997, Issue 1. Art. No: CD000219. [DOI: 10.1002/14651858.CD000219]">Glasziou 1997</a>) and updated in 1999 (<a href="./references#CD000219-bbs2-0065" title="GlasziouPP , HayemM , Del MarCB . Antibiotics versus placebo for acute otitis media in children. Cochrane Database of Systematic Reviews1999, Issue 3. Art. No: CD000219. [DOI: 10.1002/14651858.CD000219.pub2]">Glasziou 1999</a>), 2005 (<a href="./references#CD000219-bbs2-0066" title="GlasziouPP , Del MarCB , SandersSL , HayemM . Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews2005, Issue 1. Art. No: CD000219. [DOI: 10.1002/14651858.CD000219.pub2]">Glasziou 2005</a>), 2009 (<a href="./references#CD000219-bbs2-0067" title="SandersSL , GlasziouPP , Del MarCB , RoversMM . Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews2009, Issue 2. Art. No: CD000219. [DOI: 10.1002/14651858.CD000219.pub2]">Sanders 2009</a>), 2013 (<a href="./references#CD000219-bbs2-0068" title="VenekampRP , SandersS , GlasziouPP , Del MarCB , RoversMM . Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews2013, Issue 1. Art. No: CD000219. [DOI: 10.1002/14651858.CD000219.pub3]">Venekamp 2013</a>) and 2015 (<a href="./references#CD000219-bbs2-0069" title="VenekampRP , SandersS , GlasziouPP , Del MarCB , RoversMM . Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD000219. [DOI: 10.1002/14651858.CD000219.pub4]">Venekamp 2015</a>). In the 2015 update of our review (<a href="./references#CD000219-bbs2-0069" title="VenekampRP , SandersS , GlasziouPP , Del MarCB , RoversMM . Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD000219. [DOI: 10.1002/14651858.CD000219.pub4]">Venekamp 2015</a>), we identified 13 RCTs for the review of antibiotics against placebo (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>), while we judged five RCTs eligible for the review of immediate antibiotics versus expectant observation (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>) (<a href="#CD000219-fig-0003">Figure 3</a>). We excluded a total of 11 studies for various reasons (<a href="./references#CD000219-bbs2-0020" title="ArguedasA , SoleyC , KamickerBJ , JorgensenDM . Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media. International Journal of Infectious Diseases2011;15(4):e240-8. ">Arguedas 2011</a>; <a href="./references#CD000219-bbs2-0021" title="CaseyJR , BlockSL , HedrickJ , AlmudevarA , PichicheroME . Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media. Drugs2012;72:1991-7. ">Casey 2012</a>; <a href="./references#CD000219-bbs2-0022" title="Chaput de SaintongeDM , LevineDF , Temple SavageIT , BurgessGW , SharpJ , MayhewSR , et al. Trial of three-day and ten-day courses of amoxycillin in otitis media. British Medical Journal Clinical Research Edition1982;284(6322):1078-81. ">Chaput 1982</a>; <a href="./references#CD000219-bbs2-0023" title="EngelhardD , StraussN , Jorczak-SarniL , CohenD , SacjsTG , ShapiroM . Randomised study of myringotomy, amoxycillin/clavulanate, or both for acute otitis media in infants. Lancet1989;2(8655):141-3. ">Engelhard 1989</a>; <a href="./references#CD000219-bbs2-0025" title="LiuP , FangAF , LaBadieRR , CrownoverPH , ArguedasAG . Comparison of azithromycin pharmacokinetics following single oral doses of extended-release and immediate-release formulations in children with acute otitis media. Antimicrobial Agents and Chemotherapy2011;55(11):5022-6. ">Liu 2011</a>; <a href="./references#CD000219-bbs2-0026" title="OstfeldE , SegalJ , KaufsteinM , GelernterI . Management of acute otitis media without primary administration of systemic antimicrobial agents. In: LimDJ , BluestoneCD , KleinJO , NelsonJD , editors(s). Recent advances in otitis media. Proceedings of the Fourth International Symposium. Toronto: BC Decker, 1987:235-9. ">Ostfeld 1987</a>; <a href="./references#CD000219-bbs2-0027" title="RudbergRD . Acute otitis media: comparative therapeutic results of sulphonamide and penicillin administered in various forms. Acta Oto-Laryngologica1954;113(Suppl):1-79. ">Rudberg 1954</a>; <a href="./references#CD000219-bbs2-0028" title="RuoholaA , HeikkinenT , MeurmanO , PuhakkaT , LindbladN , RuuskanenO . Antibiotic treatment of acute otorrhea through tympanostomy tube: randomized double-blind placebo-controlled study with daily follow-up. Pediatrics2003;111(5):1061-7. ">Ruohola 2003</a>; <a href="./references#CD000219-bbs2-0029" title="SarrellEM , CohenHA , KahanE . Naturopathic treatment for ear pain in children. Pediatrics2003;111(5):574-9. ">Sarrell 2003</a>; <a href="./references#CD000219-bbs2-0030" title="TähtinenPA , LaineMK , RuuskanenO , RuoholaA . Delayed versus immediate antimicrobial treatment for acute otitis media. Pediatric Infectious Disease Journal2012;31(12):1227-32. ">Tähtinen 2012</a>; <a href="./references#CD000219-bbs2-0031" title="vanBuchemF , PeetersM , Van' t HofM . Acute otitis media: a new treatment strategy. BMJ1985;290:1033-7. ">van Buchem 1985</a>). </p> <div class="figure" id="CD000219-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="original image" data-id="CD000219-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <p>With the updated search (April week 3, 2015 to February week 2, 2023), we retrieved a total of 1687 records. Removing duplicates left 1103 records. After screening titles and abstracts, we identified two potentially eligible articles. After reviewing the full text, we excluded one trial since this focussed on a specific subgroup of children with AOM, i.e. those with AOM and ear discharge due to a spontaneous perforation of the ear drum (<a href="./references#CD000219-bbs2-0024" title="HayAD , MooreMV , TaylorJ , TurnerN , NobleS , CabralC , et al. Immediate oral versus immediate topical versus delayed oral antibiotics for children with acute otitis media with discharge: the REST three-arm non-inferiority electronic platform-supported RCT. Health Technology Assessment2021;25(67):1-76. ">Hay 2021</a>). This left one new trial eligible for inclusion in the review of immediate antibiotics versus expectant observation (<a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>) (<a href="#CD000219-fig-0003">Figure 3</a>). We did not identify any additional trials after reviewing the reference lists of the full‐text papers and relevant systematic reviews. We did not identify any additional ongoing trials apart from the one identified previously, which is still ongoing (<a href="./references#CD000219-bbs2-0032" title="AbbottP , GunasekeraH , LeachAJ , AskewD , WalshR , KongK , et al. A multi-centre open-label randomised non-inferiority trial comparing watchful waiting to antibiotic treatment for acute otitis media without perforation in low-risk urban Aboriginal and Torres Strait Islander children (the WATCH trial): study protocol for a randomised controlled trial. Trials2016;17(1):119. [DOI: https://doi.org/10.1186/s13063-016-1247-y] [PMID: 26941013]">the WATCH trial</a>). </p> </section> <section id="CD000219-sec-0042"> <h4 class="title">Included studies</h4> <p>Methods, participants, interventions and outcomes of the included studies are described in more detail in the table of <a href="./references#CD000219-sec-0181" title="">Characteristics of included studies</a>. </p> <section id="CD000219-sec-0043"> <h5 class="title">Antibiotics versus placebo</h5> <p>Thirteen trials including 3401 children (3938 AOM episodes) were eligible for the review of antibiotics against placebo (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>). </p> <section id="CD000219-sec-0044"> <h6 class="title">Design</h6> <p>Twelve trials were double‐blind, placebo‐controlled, parallel‐group randomised clinical trials (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>), while one trial had a 2 x 2 factorial design (<a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>). </p> </section> <section id="CD000219-sec-0045"> <h6 class="title">Participants and settings</h6> <p>The sample size of the 13 individual trials ranged from 84 children (<a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>) to 536 children (<a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>). The children were aged between two months and 15 years and 50% to 60% of included children were male. Three trials were performed in primary care (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>), six in secondary care (<a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>), and four in both primary and secondary care (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>). AOM was diagnosed by the presence of acute symptoms and otoscopic signs in nine trials (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>), and by the presence of middle ear effusion at pneumatic otoscopy and/or tympanometry in three trials (<a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>), while the criteria were not clearly described in one trial (<a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>). </p> </section> <section id="CD000219-sec-0046"> <h6 class="title">Interventions and comparators</h6> <p>Two trials compared penicillin for seven days with placebo (<a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>), four trials compared amoxicillin for seven to 14 days with or without myringotomy (surgical incision made in the tympanic membrane) with placebo (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>), and four trials compared amoxicillin/clavulanate for seven to 10 days with placebo (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>). In one trial, ampicillin for 10 days was compared with pheneticillin and sulfisoxazole and placebo (<a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>), while another trial compared erythromycin and triple sulphonamide with ampicillin, triple sulphonamide, erythromycin and placebo (<a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>). One trial, <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>, had a 2 x 2 factorial design resulting in four treatment groups: (1) sham myringotomy plus antibiotics; (2) sham myringotomy plus placebo; (3) myringotomy plus antibiotics; and (4) myringotomy plus placebo. We used all arms of this trial, so this trial was included twice in certain analyses by including both the sham myringotomy plus antibiotic versus the sham myringotomy plus placebo comparison and the myringotomy plus antibiotic versus myringotomy plus placebo comparison data. </p> </section> <section id="CD000219-sec-0047"> <h6 class="title">Outcomes</h6> <section id="CD000219-sec-0048"> <p><b>Pain</b></p> <p>Five trials (1394 children) reported data on pain at 24 hours (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>), seven (2320 children) on pain at two to three days (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>), seven (1347 children) on pain at four to seven days (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>), and one (278 children) on pain at 10 to 12 days (<a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>). </p> </section> <section id="CD000219-sec-0049"> <p><b>Adverse effects likely to be related to the use of antibiotics (vomiting, diarrhoea or rash)</b></p> <p>Eight trials (2107 children) reported data on adverse effects likely to be related to the use of antibiotics, such as vomiting, diarrhoea or rash (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>). </p> </section> <section id="CD000219-sec-0050"> <p><b>Abnormal tympanometry findings as a surrogate measure for hearing problems</b></p> <p>Seven trials (2138 children) reported data on abnormal tympanometry findings at two to four weeks (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>), three (953 children) on abnormal tympanometry findings at six to eight weeks (<a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>), and three (809 children) on abnormal tympanometry findings at three months (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>), as a surrogate measure for hearing problems caused by middle ear fluid. </p> </section> <section id="CD000219-sec-0051"> <p><b>Tympanic membrane perforation</b></p> <p>Five trials (1075 children) reported data on tympanic membrane perforation (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>). </p> </section> <section id="CD000219-sec-0052"> <p><b>Progression of symptoms (contralateral otitis or late AOM recurrences)</b></p> <p>Four trials (906 children) reported data on contralateral otitis (in unilateral cases) (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>), while six trials (2200 children) reported data on late AOM recurrences (<a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>). </p> </section> <section id="CD000219-sec-0053"> <p><b>Serious complications</b></p> <p>Ten trials reported on serious complications including mastoiditis or meningitis (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>), while information on complications was not explicitly reported in three trials (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>). </p> </section> <section id="CD000219-sec-0054"> <p><b>Long‐term effects</b></p> <p>One trial reported data on secondary care referrals at one year after randomisation as assessed by reviewing the children's notes (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>). Four children in the antibiotic group (4%) and seven in the placebo group (6%) were lost to follow‐up. </p> <p>One trial reported data on the proportion of children with AOM recurrences, secondary care referrals and ENT surgery at approximately 3.5 years after randomisation (<a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>). These long‐term outcome data were collected by questionnaires. Questionnaires were returned in 168 of the 240 children (70%) that were originally randomised. </p> </section> <section id="CD000219-sec-0055"> <p><b>Funding</b></p> <p>Seven studies received public funding from national funding bodies or from professional organisations (<a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>). For two of these, additional treatments provided to both study groups were provided by pharmaceutical companies (<a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>), and for one, the study drugs were provided by the pharmaceutical industry (<a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>). Three studies indicated that part funding was received from industry for conduct of the trial or for the provision of study drugs (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>). One study was fully funded by the pharmaceutical industry (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>). Two studies did not report on funding received (<a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>). </p> </section> <section id="CD000219-sec-0056"> <p><b>Conflicts of interest</b></p> <p>Authors of nine studies did not report on researcher conflicts of interest (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>). Two studies reported some researchers receiving industry funding for consultancy, honoraria or travel (<a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>). Two studies declared that researchers had no conflicts of interest (<a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>). </p> </section> </section> </section> <section id="CD000219-sec-0057"> <h5 class="title">Immediate antibiotics versus expectant observation</h5> <p>Six trials including a total of 1556 children were eligible for the review of immediate antibiotics versus expectant observation (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). </p> <section id="CD000219-sec-0058"> <h6 class="title">Design</h6> <p>All trials were open‐label, parallel‐group randomised clinical trials.</p> </section> <section id="CD000219-sec-0059"> <h6 class="title">Participants and settings</h6> <p>The sample size of the six individual trials ranged from 142 children (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>) to 407 children (<a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>). The children were aged 15 years and younger, and 50% to 60% of included children were male. Two trials were performed in primary care (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>), and four in secondary/tertiary care (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). AOM was diagnosed by the presence of acute symptoms and otoscopic signs in three trials (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>), by pneumatic otoscopy or preferably an aural microscope in one trial (<a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>), while diagnostic criteria or modalities used were unclear in two trials (<a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). </p> </section> <section id="CD000219-sec-0060"> <h6 class="title">Intervention and comparators</h6> <p>In two of these trials, provision of an immediate antibiotic script was compared with an antibiotic script with instructions not to commence antibiotic treatment unless the child was not better or was worse at 48 hours (<a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>) or 72 hours (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>). In these trials, 24% (36/150) and 38% (50/132) of children in the delayed arms reported using antibiotics at some stage during the illness. </p> <p>The other four trials compared immediate antibiotics with a watchful waiting approach (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>). In the <a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a> trial, children in the control group were closely monitored, especially during the first 48 hours and particularly when severe involvement was evident. In the <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a> trial, antibiotics were administered to the watchful waiting group if a child returned to the office with a treatment failure or recurrence (four children in the expectant observation group had received antibiotics by day four). In the <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a> trial, 5% (4/87) of children randomised to the watchful waiting group received antibiotics due to treatment failure, while the proportion of children receiving antibiotics during follow‐up in the watchful waiting group was not reported in the remaining trial (<a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>). </p> </section> <section id="CD000219-sec-0061"> <h6 class="title">Outcomes</h6> <p>One trial did not report any data on our primary or secondary outcomes (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>), leaving four trials from which relevant data could be extracted (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). </p> <section id="CD000219-sec-0062"> <p><b>Pain</b></p> <p>Data on pain at two to three days and three to seven days could be derived from one trial (396 included in analysis) (<a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>) and four trials (959 children) (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>), respectively. The data on pain from the <a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a> trial have been derived from data from the individual patient data (IPD) meta‐analysis (<a href="./references#CD000219-bbs2-0058" title="RoversMM , GlasziouP , AppelmanCL , BurkeP , McCormickDP , DamoiseauxRA , et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet2006;368:1429-35.">Rovers 2006</a>), while the data on pain from the <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a> trial have been provided by the author. One trial (247 children) reported data on pain at 11 to 14 days (<a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). </p> </section> <section id="CD000219-sec-0063"> <p><b>Adverse effects likely to be related to the use of antibiotics (vomiting, diarrhoea or rash)</b></p> <p>Three trials (946 children) reported data on adverse events likely to be related to the use of antibiotics such as vomiting, diarrhoea or rash (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). </p> </section> <section id="CD000219-sec-0064"> <p><b>Abnormal tympanometry findings as a surrogate measure for hearing problems</b></p> <p>One trial (207 children) reported data on abnormal tympanometry findings at two to four weeks (<a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>). </p> </section> <section id="CD000219-sec-0065"> <p><b>Tympanic membrane perforation</b></p> <p>Two trials (575 children) reported data on tympanic membrane perforation (<a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>). </p> </section> <section id="CD000219-sec-0066"> <p><b>Progression of symptoms (contralateral otitis or late AOM recurrences)</b></p> <p>None of the trials reported data on contralateral otitis (in unilateral cases), while two trials (584 children) reported data on late AOM recurrences (<a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>). </p> </section> <section id="CD000219-sec-0067"> <p><b>Serious complications</b></p> <p>Four trials reported on serious complications including mastoiditis or meningitis (<a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>), while information on complications was not explicitly reported in one trial (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>). </p> </section> <section id="CD000219-sec-0068"> <p><b>Long‐term effects</b></p> <p>One trial reported data on further ear pain episodes at three months and one year after randomisation (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>). These long‐term outcome data were collected by questionnaires. Questionnaires were returned in 219 of the 315 children (70%) that were originally randomised at one year. </p> </section> <section id="CD000219-sec-0069"> <p><b>Funding</b></p> <p>All six studies received public funding from national funding bodies or professional organisations (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>), including one that received study drugs provided by the pharmaceutical industry (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>). </p> </section> <section id="CD000219-sec-0070"> <p><b>Conflicts of interest</b></p> <p>Three studies declared researchers had no conflicts of interest (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>), and three studies did not report on researcher conflicts of interest (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). </p> </section> </section> </section> </section> <section id="CD000219-sec-0071"> <h4 class="title">Excluded studies</h4> <p>We excluded 12 studies after reviewing the full text. Three were non‐randomised studies (<a href="./references#CD000219-bbs2-0026" title="OstfeldE , SegalJ , KaufsteinM , GelernterI . Management of acute otitis media without primary administration of systemic antimicrobial agents. In: LimDJ , BluestoneCD , KleinJO , NelsonJD , editors(s). Recent advances in otitis media. Proceedings of the Fourth International Symposium. Toronto: BC Decker, 1987:235-9. ">Ostfeld 1987</a>; <a href="./references#CD000219-bbs2-0027" title="RudbergRD . Acute otitis media: comparative therapeutic results of sulphonamide and penicillin administered in various forms. Acta Oto-Laryngologica1954;113(Suppl):1-79. ">Rudberg 1954</a>; <a href="./references#CD000219-bbs2-0031" title="vanBuchemF , PeetersM , Van' t HofM . Acute otitis media: a new treatment strategy. BMJ1985;290:1033-7. ">van Buchem 1985</a>), while three other studies had no comparison of antibiotics with placebo or expectant observation (<a href="./references#CD000219-bbs2-0021" title="CaseyJR , BlockSL , HedrickJ , AlmudevarA , PichicheroME . Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media. Drugs2012;72:1991-7. ">Casey 2012</a>; <a href="./references#CD000219-bbs2-0023" title="EngelhardD , StraussN , Jorczak-SarniL , CohenD , SacjsTG , ShapiroM . Randomised study of myringotomy, amoxycillin/clavulanate, or both for acute otitis media in infants. Lancet1989;2(8655):141-3. ">Engelhard 1989</a>; <a href="./references#CD000219-bbs2-0029" title="SarrellEM , CohenHA , KahanE . Naturopathic treatment for ear pain in children. Pediatrics2003;111(5):574-9. ">Sarrell 2003</a>). Two trials studied the effectiveness of short‐ versus long‐course antibiotics (<a href="./references#CD000219-bbs2-0020" title="ArguedasA , SoleyC , KamickerBJ , JorgensenDM . Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media. International Journal of Infectious Diseases2011;15(4):e240-8. ">Arguedas 2011</a>; <a href="./references#CD000219-bbs2-0022" title="Chaput de SaintongeDM , LevineDF , Temple SavageIT , BurgessGW , SharpJ , MayhewSR , et al. Trial of three-day and ten-day courses of amoxycillin in otitis media. British Medical Journal Clinical Research Edition1982;284(6322):1078-81. ">Chaput 1982</a>), one trial studied a single‐dose antibiotic with slow versus immediate‐release formulations (<a href="./references#CD000219-bbs2-0025" title="LiuP , FangAF , LaBadieRR , CrownoverPH , ArguedasAG . Comparison of azithromycin pharmacokinetics following single oral doses of extended-release and immediate-release formulations in children with acute otitis media. Antimicrobial Agents and Chemotherapy2011;55(11):5022-6. ">Liu 2011</a>), whereas another trial was conducted in children with ventilation tubes (<a href="./references#CD000219-bbs2-0028" title="RuoholaA , HeikkinenT , MeurmanO , PuhakkaT , LindbladN , RuuskanenO . Antibiotic treatment of acute otorrhea through tympanostomy tube: randomized double-blind placebo-controlled study with daily follow-up. Pediatrics2003;111(5):1061-7. ">Ruohola 2003</a>). Moreover, we excluded one trial report as this study reported on the effectiveness of immediate versus delayed antibiotic prescription based on a secondary analysis of a placebo‐controlled trial (<a href="./references#CD000219-bbs2-0030" title="TähtinenPA , LaineMK , RuuskanenO , RuoholaA . Delayed versus immediate antimicrobial treatment for acute otitis media. Pediatric Infectious Disease Journal2012;31(12):1227-32. ">Tähtinen 2012</a>). Finally, we excluded another trial report as this study reported on the effectiveness of immediate oral antibiotics versus immediate topical antibiotics versus delayed oral antibiotics for children with acute otitis media and ear discharge due to a spontaneous perforation of the ear drum (<a href="./references#CD000219-bbs2-0024" title="HayAD , MooreMV , TaylorJ , TurnerN , NobleS , CabralC , et al. Immediate oral versus immediate topical versus delayed oral antibiotics for children with acute otitis media with discharge: the REST three-arm non-inferiority electronic platform-supported RCT. Health Technology Assessment2021;25(67):1-76. ">Hay 2021</a>). This is a population that generally has a poorer prognosis with higher rates of ear pain and/or fever at three to seven days and more AOM recurrences and hearing problems at three months than children presenting with AOM without ear discharge (<a href="./references#CD000219-bbs2-0058" title="RoversMM , GlasziouP , AppelmanCL , BurkeP , McCormickDP , DamoiseauxRA , et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet2006;368:1429-35.">Rovers 2006</a>; <a href="./references#CD000219-bbs2-0059" title="SmithL , EwingsP , SmithC , ThompsonM , HarndenA , MantD . Ear discharge in children presenting with acute otitis media: observational study from UK general practice. British Journal of General Practice2010;60(571):101-5.">Smith 2010</a>). </p> </section> </section> <section id="CD000219-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p>The methodological quality of the included studies was generally high. For further details on the risk of bias in included studies, see the risk of bias summary (<a href="#CD000219-fig-0001">Figure 1</a>) and risk of bias graph (<a href="#CD000219-fig-0002">Figure 2</a>). </p> <section id="CD000219-sec-0073"> <h4 class="title">Allocation</h4> <p>Random sequence generation was adequate in seven of the 13 trials (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>), and in three of the six included trials (<a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>), respectively. </p> <p>Concealment of allocation was adequately described in 11 of the 13 included trials comparing antibiotics with placebo (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>), and two out of six trials comparing immediate antibiotics with expectant observation (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). </p> </section> <section id="CD000219-sec-0074"> <h4 class="title">Blinding</h4> <p>All included trials in the review of antibiotics against placebo stated that they were double‐blinded. However, we judged blinding to be adequate in eight of the 13 included trials (<a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>). All six trials comparing immediate antibiotics with expectant observation were open‐label trials (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). As a consequence, reporting of the child's symptoms by parents was not blinded in these trials. However, investigators were blinded in two of the six trials (<a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). </p> </section> <section id="CD000219-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>The loss to follow‐up was below 5% in eight of the 13 trials comparing antibiotics with placebo (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>). Loss to follow‐up was high in three trials with a total loss to follow‐up of 15% (<a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>), 7% (<a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>) and 12% (<a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>), respectively. However, one of these trials included all randomised patients in the primary analysis at day four (<a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>). In two of the 13 trials, the total numbers of loss to follow‐up/exclusions are described, but it was unclear from which treatment group children were excluded (<a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>). For the review of immediate antibiotics against expectant observation, the loss to follow‐up was below 5% in two of the five trials (<a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>). The total loss to follow‐up in the other trials was 11% (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>), 10% (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>), 6% (<a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>) and 5.3% (<a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>), respectively. </p> </section> <section id="CD000219-sec-0076"> <h4 class="title">Selective reporting</h4> <p>Three of the 13 included trials comparing antibiotics with placebo had their study protocol registered (<a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>; <a href="./references#CD000219-bbs2-0017" title="TapiainenT , KujalaT , RenkoM , KoivunenP , KontiokariT , KristoA , et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatrics2014;168(7):635-41. ">Tapiainen 2014</a>), while in the remaining 10 trials no study protocol or trial registry was found and we judged the risk of outcome reporting bias to be unclear (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>). For the review of immediate antibiotics versus expectant observation, two of the six included trials had their study protocol registered (<a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>), while in the remaining four trials no study protocol or trial registry was found and we judged the risk of outcome reporting bias to be unclear (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>). </p> <p>The funnel plot for pain at the various time points did not reveal asymmetry (<a href="#CD000219-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD000219-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Antibiotic versus placebo, outcome: 1.1 Pain." data-id="CD000219-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus placebo, outcome: 1.1 Pain.</p> </div> </div> </div> </section> <section id="CD000219-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>Eight of the 13 included trials comparing antibiotics with placebo used intention‐to‐treat (ITT) analyses, while in the other five this was not clear (<a href="./references#CD000219-bbs2-0004" title="HalstedC , LepowML , BalassanianN , EmmerichJ , WolinskyE . Otitis media: clinical observation, microbiology and evaluation of therapy. American Journal of Diseases of Children1968;115(5):542-51. ">Halsted 1968</a>; <a href="./references#CD000219-bbs2-0006" title="HowieVM , PloussardJH . Efficacy of fixed combination antibiotics versus separate components in otitis media: effectiveness of erythromycin estolate, triple sulfonamide, ampicillin, erythromycin estolate-triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clinical Pediatrics1972;11(4):205-14. ">Howie 1972</a>; <a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>; <a href="./references#CD000219-bbs2-0018" title="ThalinA , DensertO , LarssonA , LydenE , RipaT . Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media 1985, Jerusalem. Amsterdam: Kugler Publications, 1985:441-6. ">Thalin 1985</a>; <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>). For the review of immediate antibiotics versus expectant observation, three of the six included trials used ITT analyses, while this was not clear in the other three trials (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>). </p> <p>No other potential sources of bias could be detected in the included trials, except for the <a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a> trial, which we judged as having a high risk of detection bias since children in the control group were subjected to very close scrutiny, especially during the first 48 hours and particularly when severe involvement was evident. However, this trial did not report any data on our primary or secondary outcomes. </p> </section> </section> <section id="CD000219-sec-0078"> <h3 class="title" id="CD000219-sec-0078">Effects of interventions</h3> <p>See: <a href="./full#CD000219-tbl-0001"><b>Summary of findings 1</b> Antibiotics versus placebo for acute otitis media in children</a>; <a href="./full#CD000219-tbl-0002"><b>Summary of findings 2</b> Immediate antibiotics versus expectant observation for acute otitis media in children</a> </p> <section id="CD000219-sec-0079"> <h4 class="title">Antibiotics versus placebo</h4> <section id="CD000219-sec-0080"> <h5 class="title">Primary outcomes</h5> <section id="CD000219-sec-0081"> <h6 class="title">1. Proportion of children with pain at various time points</h6> <p>Antibiotics do not reduce pain at 24 hours (risk ratio (RR) 0.89, 95% confidence interval (CI) 0.78 to 1.01; 5 trials, 1394 children) and at four to seven days (RR 0.76, 95% CI 0.50 to 1.14; 7 trials, 1264 children), but result in almost a third fewer children having pain at two to three days (RR 0.71, 95% CI 0.58 to 0.88; 7 trials, 2320 children), and likely result in two‐thirds fewer having pain at 10 to 12 days (RR 0.33, 95% CI 0.17 to 0.66; 1 trial, 278 children) (<a href="./references#CD000219-fig-0007" title="">Analysis 1.1</a>). </p> <p>This means that 5% (95% CI 2% to 7%) fewer children had pain after two to three days (number needed to treat for an additional beneficial outcome (NNTB) 20; 95% CI 14 to 50), and 14% (95% CI 6% to 22%) fewer children had pain after 10 to 12 days (NNTB 7; 95% CI 4 to 16) with antibiotics, respectively. </p> <p>Plots of the event rate (pain) in the treatment and control groups for each study at 24 hours and two to three days are reported in <a href="#CD000219-fig-0005">Figure 5</a> and <a href="#CD000219-fig-0006">Figure 6</a>. </p> <div class="figure" id="CD000219-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="L'Abbé plot of the rates of pain at 24 hours for the placebo (control) versus antibiotic (experimental) group." data-id="CD000219-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-05.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>L'Abbé plot of the rates of pain at 24 hours for the placebo (control) versus antibiotic (experimental) group. </p> </div> </div> </div> <div class="figure" id="CD000219-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="L'Abbé plot of the rates of pain at two to three days for the placebo (control) versus antibiotic (experimental) group." data-id="CD000219-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-06.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>L'Abbé plot of the rates of pain at two to three days for the placebo (control) versus antibiotic (experimental) group. </p> </div> </div> </div> <section id="CD000219-sec-0082"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence on pain at 24 hours, two to three days and four to seven days to be of high certainty, while we judged the evidence on pain at 10 to 12 days to be of moderate certainty. We downgraded the evidence for pain at days 10 to 12 as this outcome was not specified a priori in this trial (secondary analysis). </p> </section> </section> <section id="CD000219-sec-0083"> <h6 class="title">2. Adverse effects likely to be related to the use of antibiotics</h6> <p>Antibiotics result in a 38% (95% CI 16% to 63%; 8 trials, 2107 children) relative increase in the risk of adverse effects likely to be related to the use of antibiotics (defined as vomiting, diarrhoea or rash) compared with placebo; 27% (283/1044) of children treated with antibiotics versus 20% (208/1063) of children treated with placebo experienced vomiting, diarrhoea or rash (<a href="./references#CD000219-fig-0008" title="">Analysis 1.2</a>). The number needed to treat for an additional harmful outcome (NNTH) was 14 (9 to 26). </p> <section id="CD000219-sec-0084"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for adverse effects likely to be related to the use of antibiotics (vomiting, diarrhoea or rash) to be of high certainty. </p> </section> </section> </section> <section id="CD000219-sec-0085"> <h5 class="title">Secondary outcomes</h5> <section id="CD000219-sec-0086"> <h6 class="title">1. Abnormal tympanometry findings at various time points</h6> <p>Antibiotics result in a 17% (95% CI 4% to 28%; 7 trials, 2138 children) relative reduction in the risk of abnormal tympanometry findings at two to four weeks (<a href="./references#CD000219-fig-0009" title="">Analysis 1.3</a>). This means that 9% (95% CI 5% to 13%) fewer children had abnormal tympanometry findings at two to four weeks (NNTB 11, 95% CI 7 to 20). </p> <p>However, antibiotics do not reduce the risk of abnormal tympanometry findings at six to eight weeks (RR 0.89, 95% CI 0.70 to 1.13; 3 trials, 953 children), and at three months (RR 0.94, 95% CI 0.66 to 1.34; 3 trials, 809 children) (<a href="./references#CD000219-fig-0009" title="">Analysis 1.3</a>). Furthermore, audiometry was done in only two studies and incompletely reported. The two studies that used audiograms were <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a> and <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>: (i) <a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a> reported that, "After one month, 31% of the patients showed an air/bone gap of more than 20 dB. After two months, this was still the case with 19% of the patients. Here again, there were no significant differences between the groups"; (ii) <a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a> stated that "Analysis of hearing acuity in children two years of age and older indicated that elevated hearing thresholds ... bore no apparent relationship ... to mode of treatment (amoxicillin versus placebo)". </p> <section id="CD000219-sec-0087"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for abnormal tympanometry findings at the various time points to be of high certainty. </p> </section> </section> <section id="CD000219-sec-0088"> <h6 class="title">2. Tympanic membrane perforation</h6> <p>Antibiotic treatment is associated with a 57% (95% CI 11% to 79%; 5 trials, 1075 children) relative reduction in the risk of tympanic membrane perforation compared with placebo (<a href="./references#CD000219-fig-0010" title="">Analysis 1.4</a>). However, absolute benefits of antibiotics appeared to be small: 3% (95% CI 1% to 5%) fewer children had a tympanic membrane perforation. Therefore, 33 children (95% CI 20 to 100) needed to be treated to prevent one child experiencing a tympanic membrane perforation. </p> <section id="CD000219-sec-0089"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for tympanic membrane perforation to be of high certainty.</p> </section> </section> <section id="CD000219-sec-0090"> <h6 class="title">3. Contralateral otitis</h6> <p>Antibiotics result in a 51% (95% CI 5% to 75%; 4 trials, 906 children) relative reduction in the development of contralateral otitis compared with placebo (<a href="./references#CD000219-fig-0011" title="">Analysis 1.5</a>). This means that 9% (95% CI 5% to 13%) fewer children had contralateral otitis (NNTB 11, 95% CI 7 to 20). </p> <section id="CD000219-sec-0091"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for contralateral otitis to be of high certainty.</p> </section> </section> <section id="CD000219-sec-0092"> <h6 class="title">4. Acute otitis media (AOM) recurrences</h6> <p>AOM recurrences were common. <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a> stated "The mean number of recorded recurrences of otitis media or acute red ear was 0.70 (range 0 to 4) in the antibiotic group and 0.63 (range 0 to 7) in the placebo group and this difference was not significant (difference 0.06, 95% CI ‐0.22 to 0.339)." Six other trials reported the proportions who relapsed; the combined results were consistent with Burke's findings and indicate that antibiotics do not reduce the occurrence of late AOM recurrences compared with placebo (RR 0.94, 95% CI 0.79 to 1.11; 6 trials, 2200 children) (<a href="./references#CD000219-fig-0012" title="">Analysis 1.6</a>). </p> <section id="CD000219-sec-0093"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for late AOM recurrences to be of high certainty.</p> </section> </section> <section id="CD000219-sec-0094"> <h6 class="title">5. Serious complications related to AOM</h6> <p>Few serious complications occurred in either the antibiotic treatment group or the control group. In just over 3000 children studied, only one case of mastoiditis occurred in both the antibiotic group (<a href="./references#CD000219-bbs2-0012" title="MygindN , Meistrup-Larsen K-I, ThomsenJ , ThomsenVF , JosefssonK , SorensenH . Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clinical Otolaryngology1981;6:5-13. ThomsenJ , Meistrup-LarsenKI , SorensenH , LarsenPK , MygindN . Penicillin and acute otitis: short and long term results. Annals of Otology, Rhinology and Laryngology, Supplement1980;89:271-4. ">Mygind 1981</a>) and the placebo group (<a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>). Moreover, one child suffered from meningitis (<a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>), pneumococcal bacteraemia and radiologically confirmed pneumonia (<a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>) in the placebo group and one child had transient facial paralysis in the antibiotic group (<a href="./references#CD000219-bbs2-0007" title="KaleidaPH , CasselhrantML , RocketteHE , ParadiseJL , BluestoneCD , BlatterMM , et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Paediatrics1991;87(4):466-74. ">Kaleida 1991</a>). Hence, the applicability of these findings to groups of children in whom serious complications such as mastoiditis is common is uncertain. One of the excluded studies did report high rates of mastoiditis (<a href="./references#CD000219-bbs2-0027" title="RudbergRD . Acute otitis media: comparative therapeutic results of sulphonamide and penicillin administered in various forms. Acta Oto-Laryngologica1954;113(Suppl):1-79. ">Rudberg 1954</a>). This was an open, semi‐randomised study conducted in Sweden in 1954. Participants were randomised by case‐sheet number but a proportion (about 30 of 220) requested, and were granted, entry to the penicillin group. The rate of mastoiditis was 17% in the untreated group versus 1.5% in the sulphonamide‐treated group and 0% in the penicillin‐treated group. The biases of this study (semi‐randomisation and unblinded outcome assessment) are unlikely to explain such a large difference. </p> <section id="CD000219-sec-0095"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for serious complications to be of low certainty. We downgraded the evidence from high certainty due to serious concerns about imprecision (we considered the sample size to be insufficient to draw any definite conclusions based on these data). </p> </section> </section> <section id="CD000219-sec-0096"> <h6 class="title">6. Long‐term effects</h6> <p>Based on reviewing children's notes, antibiotics do not reduce the number of secondary care referrals at one year after randomisation: 7/110 (6%) in the antibiotic group and 9/111 (8%) in the placebo group (RR 0.78, 95% 0.30 to 2.03). </p> <p>Based on questionnaires returned by parents approximately 3.5 years after initial randomisation, AOM recurrence was observed in 63% (47/75) of children in the immediate antibiotics group and in 43% (37/86) of the placebo group. Immediate antibiotics therefore likely result in a 46% (95% CI 8% to 97%) relative increase in the risk of AOM recurrences compared to placebo. This means that 20% (95% CI 5% to 35%) more children had AOM recurrences (NNTH 5, 95% CI 2 to 20) when receiving immediate antibiotics. No between‐group differences were observed for secondary care referrals. Furthermore, antibiotics were not associated with a statistically significant reduction in the number of ear, nose and throat surgeries (RR 0.68, 95% CI 0.40 to 1.17). </p> <section id="CD000219-sec-0097"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for long‐term effects at one year to be of high certainty, while we judged the 3.5 years data to be of moderate certainty. We mainly downgraded the evidence because of the high proportion of children that were not included in the analysis (30%), which introduced a significant risk of (attrition) bias. </p> </section> </section> </section> </section> <section id="CD000219-sec-0098"> <h4 class="title">Immediate antibiotics versus expectant observation</h4> <section id="CD000219-sec-0099"> <h5 class="title">Primary outcomes</h5> <section id="CD000219-sec-0100"> <h6 class="title">1. Proportion of children with pain at various time points</h6> <p>The evidence suggests that immediate antibiotics may result in a reduction of pain at two to three days (RR 0.53, 95% CI 0.35 to 0.79; NNTB 8; 1 trial, 396 children), but probably do not reduce the risk of pain at three to seven days (RR 0.75, 95% CI 0.50 to 1.12; 4 trials, 959 children), and may not reduce the risk of pain at 11 to 14 days (RR 0.91, 95% CI 0.75 to 1.10; 1 trial, 247 children) compared with expectant observation (<a href="./references#CD000219-fig-0013" title="">Analysis 2.1</a>). </p> <section id="CD000219-sec-0101"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence on pain at three to seven days to be of moderate certainty, while we judged the evidence on pain at two to three days and 11 to 14 days to be of low certainty. We downgraded the evidence because of study limitations (risk of detection bias) and further downgraded the evidence for pain at two to three days because of imprecision (outcome data derived from one trial), and pain at days 11 to 14 because of the number of children that were 'lost to follow‐up' (13%), which introduced a risk of (attrition) bias. </p> </section> </section> <section id="CD000219-sec-0102"> <h6 class="title">2. Adverse effects likely to be related to the use of antibiotics</h6> <p>Immediate antibiotics result in an 87% (95% CI 39% to 151%; 3 trials, 946 children) relative increase in the risk of adverse effects likely to be related to the use of antibiotics (defined as vomiting, diarrhoea or rash) compared with expectant observation; 22% (101/456) of children treated with immediate antibiotics versus 11% (56/490) of children treated with expectant observation experienced vomiting, diarrhoea or rash (<a href="./references#CD000219-fig-0014" title="">Analysis 2.2</a>). The NNTH was 10. </p> <section id="CD000219-sec-0103"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for adverse effects likely to be related to the use of antibiotics (vomiting, diarrhoea or rash) to be of high certainty. </p> </section> </section> </section> <section id="CD000219-sec-0104"> <h5 class="title">Secondary outcomes</h5> <section id="CD000219-sec-0105"> <h6 class="title">1. Abnormal tympanometry findings at various time points</h6> <p>Immediate antibiotics probably do not reduce the proportion of children with abnormal tympanometry findings at four weeks compared with expectant observation (RR 1.03, 95% CI 0.78 to 1.35; 1 trial, 207 children; <a href="./references#CD000219-fig-0015" title="">Analysis 2.3</a>). </p> <section id="CD000219-sec-0106"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for abnormal tympanometry findings at four weeks to be of moderate certainty. We downgraded the evidence from high certainty as the number of children that were 'lost to follow‐up' in the immediate antibiotics group was substantially lower than in the expectant observation group (4% versus 11%), thereby introducing a risk of (attrition) bias. </p> </section> </section> <section id="CD000219-sec-0107"> <h6 class="title">2. Tympanic membrane perforation</h6> <p>Only three tympanic membrane perforations (two in the immediate antibiotics group versus one in the expectant observation group) were observed in one trial (396 children) (<a href="./references#CD000219-bbs2-0014" title="ShahbaznejadL , TalaeiE , HosseinzadehF , MasoumiB , RezaiS , RezaiMS . Comparing watchful waiting approach vs. antibiotic therapy in children with nonsevere acute otitis media: a randomized clinical trial. International Journal of Pediatrics2021;-:5515467. [DOI: https://doi.org/10.1155/2021/5515467] [PMID: 34135974]">Shahbaznejad 2021</a>), whereas none were observed in either group in the other trial (179 children) (<a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>). The evidence suggests that immediate antibiotics may not reduce the risk of tympanic membrane perforation (RR 2.21, 95% CI 0.20 to 24.21; 3 trials, 575 children; <a href="./references#CD000219-fig-0016" title="">Analysis 2.4</a>) compared with expectant observation. </p> <section id="CD000219-sec-0108"> <p><b>Certainty of evidence</b></p> <p>We judged the data on tympanic membrane perforation to be of low certainty. We downgraded the evidence because of study limitations (risk of detection bias) and imprecision. </p> </section> </section> <section id="CD000219-sec-0109"> <h6 class="title">3. Contralateral otitis</h6> <p>None of the trials reported data on contralateral otitis.</p> </section> <section id="CD000219-sec-0110"> <h6 class="title">4. AOM recurrences</h6> <p>The evidence suggests that immediate antibiotics may not reduce the risk of AOM recurrences (RR 1.04, 95% CI 0.77 to 1.41; 2 trials, 584 children; <a href="./references#CD000219-fig-0017" title="">Analysis 2.5</a>) compared with expectant observation. </p> <section id="CD000219-sec-0111"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for AOM recurrences to be of low certainty. We downgraded the evidence because of study limitations (risk of detection bias and risk of attrition bias). </p> </section> </section> <section id="CD000219-sec-0112"> <h6 class="title">5. Serious complications related to AOM</h6> <p>No serious complications occurred in either the immediate antibiotic group or the expectant observation group. </p> <section id="CD000219-sec-0113"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for serious complications to be of very low certainty since we considered the sample size to be insufficient to draw any robust conclusions based on these data. </p> </section> </section> <section id="CD000219-sec-0114"> <h6 class="title">6. Long‐term effects</h6> <p>Immediate antibiotics may not reduce the risk of parent‐reported ear pain episodes at one year (odds ratio (OR) 1.03, 95% CI 0.60 to 1.78; 1 trial, 219 children) compared with expectant observation (delayed antibiotics). </p> <section id="CD000219-sec-0115"> <p><b>Certainty of evidence</b></p> <p>We judged the evidence for long‐term effects to be of low certainty. We mainly downgraded because this evidence was derived from a secondary analysis and because of the high proportion of children that were not included in the analysis at one year (30%), which introduced a significant risk of (attrition) bias. </p> </section> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000219-sec-0116" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000219-sec-0116"></div> <section id="CD000219-sec-0117"> <h3 class="title" id="CD000219-sec-0117">Summary of main results</h3> <p>This review reveals that antibiotics have no early effect on pain, a slight effect on pain in the days following and only a modest effect on the number of children with tympanic perforations, contralateral otitis episodes and abnormal tympanometry findings at two to four weeks compared with placebo in children with acute otitis media (AOM). However, in applying these results, there are a number of issues to consider, including the individual potential for serious complications and subgroups of children in whom there may be greater benefits. </p> </section> <section id="CD000219-sec-0118"> <h3 class="title" id="CD000219-sec-0118">Overall completeness and applicability of evidence</h3> <p>Does the effect vary in different clinical groups? The estimated numbers needed to treat for the outcome pain are for the 'average' case and may vary in subgroups. Several studies reported higher rates of failure of placebo treatment amongst children less than two years of age and those with bilateral disease (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>), and another trial has suggested that most benefit is seen in children with high fever or vomiting (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>). Moreover, some studies found that children with bilateral AOM differ with regards to clinical and microbiological (increased presence of (non‐typeable) <i>H influenzae</i>) characteristics compared with children with unilateral AOM (<a href="./references#CD000219-bbs2-0036" title="BarkaiG , LeibovitzE , Givon-LaviN , DaganR . Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatric Infectious Disease Journal2009;28:466-71.">Barkai 2009</a>; <a href="./references#CD000219-bbs2-0054" title="McCormickDP , ChandlerSM , ChonmaitreeT . Laterality of acute otitis media: different clinical and microbiologic characteristics. Pediatric Infectious Disease Journal2007;26:583-8.">McCormick 2007</a>). However, an individual patient data (IPD) meta‐analysis performed in 2006 (<a href="./references#CD000219-bbs2-0058" title="RoversMM , GlasziouP , AppelmanCL , BurkeP , McCormickDP , DamoiseauxRA , et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet2006;368:1429-35.">Rovers 2006</a>), using data from six high‐certainty RCTs, including a total of 1643 children, which were also included in this review as individual trials (<a href="./references#CD000219-bbs2-0001" title="AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ1991;303:1450-2. AppelmanCL , ClaessenJQ , Touw OttenFW , HordijkGJ , deMelkerRA . Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ1993;306:895. ClaessenJQ , AppelmanCL , Touw OttenFW , deMelkerRA , HordijkGJ . Persistence of middle ear dysfunction after recurrent acute otitis media. Clinical Otolaryngology1994;19:35-40. ">Appelman 1991</a>; <a href="./references#CD000219-bbs2-0002" title="BurkeP , BainJ , RobinsonD , DunleaveyJ . Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ1991;303:558-62. ">Burke 1991</a>; <a href="./references#CD000219-bbs2-0003" title="BezákováN , DamoiseauxRA , HoesAW , SchilderAG , RoversMM . Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. BMJ2009;338:b2525. DamoiseauxRAMJ , vanBalenFAM , HoesAW , VerheijTJM , deMelkerRA . Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ2000;320:350-4. ">Damoiseaux 2000</a>; <a href="./references#CD000219-bbs2-0009" title="Le SauxN , GabouryI , BairdM , KlassenTP , MacCormickJ , BlanchardC , et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. Canadian Medical Association Journal2005;172(3):335-41. ">Le Saux 2005</a>; <a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>), demonstrated that the relative effects of antibiotics were not significantly modified by either age or bilateral disease alone, but the absolute differences were larger in the younger patients (less than two years) with bilateral disease and in those with both AOM and otorrhoea. Whether topical antibiotics are an appropriate alternative to oral antibiotics in children with both AOM and otorrhoea due to a spontaneous tympanic membrane perforation remains to be elucidated (<a href="./references#CD000219-bbs2-0024" title="HayAD , MooreMV , TaylorJ , TurnerN , NobleS , CabralC , et al. Immediate oral versus immediate topical versus delayed oral antibiotics for children with acute otitis media with discharge: the REST three-arm non-inferiority electronic platform-supported RCT. Health Technology Assessment2021;25(67):1-76. ">Hay 2021</a>). Further analysis of the IPD has shown that age younger than two years is an independent predictor of the development of asymptomatic middle ear effusion (<a href="./references#CD000219-bbs2-0050" title="KoopmanL , HoesAW , GlasziouPP , AppelmanCL , BurkeP , McCormickDP , et al. Antibiotic therapy to prevent the development of asymptomatic middle ear effusion in children with acute otitis media. Archives of Otolaryngology - Head and Neck Surgery2008;134(2):128-32.">Koopman 2008</a>). This analysis also found that antibiotic therapy has a marginal effect on the development of asymptomatic middle ear effusion in children with AOM. </p> <p>Does the impact vary by duration and dose of antibiotics? Most trials use seven days of antibiotic treatment. A meta‐analysis of a short (less than seven days) versus long (more than seven days) course of antibiotics reported that risk of treatment failure at one month was higher with short courses of antibiotics (odds ratio (OR) 1.34, 95% confidence interval (CI) 1.15 to 1.55) (<a href="./references#CD000219-bbs2-0051" title="KozyrskyjA , KlassenTP , MoffattM , HarveyK . Short-course antibiotics for acute otitis media. Cochrane Database of Systematic Reviews2010, Issue 9. Art. No: CD001095. [DOI: 10.1002/14651858.CD001095]">Kozyrskyj 2010</a>). However, the absolute difference in treatment effect was small (3%) and short courses of antibiotics were associated with a statistically significant reduction in gastrointestinal adverse events compared with longer courses. A recommendation regarding the most appropriate dose of antibiotics is not possible due to a lack of sufficient data. </p> <p>What are the potential consequences of not using antibiotics? Besides the immediate pain associated with AOM, there are some more serious complications. Though only two cases of mastoiditis were reported in the included trials (one child received antibiotics and one child was assigned to placebo), a semi‐randomised trial in Sweden in 1954 reported a rate of 17% in the untreated group versus none in the penicillin‐treated groups (<a href="./references#CD000219-bbs2-0027" title="RudbergRD . Acute otitis media: comparative therapeutic results of sulphonamide and penicillin administered in various forms. Acta Oto-Laryngologica1954;113(Suppl):1-79. ">Rudberg 1954</a>). In populations or sub‐populations where mastoiditis is still judged a frequent problem, such as in some low‐income countries, antibiotic treatment would be strongly advised (<a href="./references#CD000219-bbs2-0037" title="BermanS . Otitis media in developing countries. Pediatrics1995;96:126-31.">Berman 1995</a>). </p> <p>Of note is an article that revealed that doctors commonly over‐diagnose AOM (<a href="./references#CD000219-bbs2-0057" title="RothmanR , OwensT , SimelD . Does this child have acute otitis media?JAMA2003;290(12):1633-40.">Rothman 2003</a>). What effect might this have on the efficacy of antibiotics (or any treatment)? One effect will be to blunt any treatment effect by dilution (from the cases of non‐AOM). The results of two performed trials (<a href="./references#CD000219-bbs2-0005" title="HobermanA , ParadiseJL , RocketteHE , ShaikhN , WaldER , KearneyDH , et al. Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine2011;364(2):105-15. ParadiseJL , HobermanA , RocketteHE , ShaikhN . Treating acute otitis media in young children: what constitutes success?Pediatric Infectious Disease Journal2013;32(7):745-7. ">Hoberman 2011</a>; <a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>), in which AOM had been diagnosed with the use of stringent criteria (including pneumatic otoscopic examination in one trial) (<a href="./references#CD000219-bbs2-0016" title="TähtinenPA , LaineMK , HuovinenP , JalavaJ , RuuskanenO , RuoholaA . A placebo-controlled trial of antimicrobial treatment for acute otitis media. New England Journal of Medicine2011;364(2):116-26. ">Tähtinen 2011</a>), underline this phenomenon. Nevertheless, physicians in daily practice are likely to use the same diagnostic methods (perhaps even less stringent) as used in the majority of the included trials in this review. As a consequence, the effectiveness of antibiotics reported in this review is likely to be a true reflection of the effectiveness in actual clinical practice. However, if new and more accurate diagnostic procedures are introduced in future daily practice, then the current estimate of effectiveness will have to be reconsidered. </p> </section> <section id="CD000219-sec-0119"> <h3 class="title" id="CD000219-sec-0119">Certainty of the evidence</h3> <p>The methodological quality of the included studies was generally high. We judged the evidence to be of high certainty for most of the outcomes in the review of antibiotics against placebo. We judged the certainty of evidence to be moderate for pain at 10 to 12 days and long‐term effects (3.5 years data), and low for serious complications. We downgraded the evidence mainly because of the risk of reporting bias (pain at 10 to 12 days) and attrition bias (long‐term effects), and because of sample size considerations (serious complications). </p> <p>For the review of immediate antibiotics versus expectant observation, we judged the evidence to be of low certainty for most of the outcomes. We downgraded the evidence mainly because of study limitations (risk of detection bias and/or selection bias), imprecision and sample size considerations. </p> </section> <section id="CD000219-sec-0120"> <h3 class="title" id="CD000219-sec-0120">Potential biases in the review process</h3> <p>There was some clinical heterogeneity amongst the included trials. For example, patients were recruited from different settings (general practice, ear, nose and throat, and paediatric clinics). However, the majority of included trials did use a diagnostic method (clinical diagnosis of AOM as inclusion criteria) that resembles daily clinical practice. Besides, duration and dosage of the antibiotic treatment varied to some extent. For the review of antibiotics against placebo, the duration of antibiotic treatment varied from seven to 14 days. However, we do not consider this as a major drawback, since most trials used seven days of antibiotic treatment and current evidence indicates only a small absolute treatment difference (3%) in treatment failure at one month in favour of a long (more than seven days) versus a short (less than seven days) course of antibiotics. Moreover, the primary outcome of this review (proportion of children with pain) is reported within the first seven days of antibiotic treatment. In addition, we assessed funnel plots for potential reporting biases for the primary analysis (<a href="#CD000219-fig-0004">Figure 4</a>). No asymmetry could be detected in the included trials. </p> </section> <section id="CD000219-sec-0121"> <h3 class="title" id="CD000219-sec-0121">Agreements and disagreements with other studies or reviews</h3> <p>This review demonstrated that at 24 hours, pain had recovered spontaneously in 60% of children and that the majority had recovered in the following two to 12 days, regardless of whether they had received placebo or antibiotics. However, the IPD meta‐analysis, which included six of the trials included in this review, revealed a slower rate of recovery with only 22% of children experiencing spontaneous recovery at 24 hours (<a href="./references#CD000219-bbs2-0058" title="RoversMM , GlasziouP , AppelmanCL , BurkeP , McCormickDP , DamoiseauxRA , et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet2006;368:1429-35.">Rovers 2006</a>). There are a number of possible explanations for this. First, data from older trials were not included in the IPD meta‐analysis and consequently the study population may reflect a higher threshold of doctor visitation; for example, the children may be 'sicker' or presenting to the doctor later in the course of their illness. Variation in the definitions of pain/no pain cut‐offs amongst the trials included in the reviews may also explain some of this variation. The IPD meta‐analysis indicated that antibiotics had the greatest effect compared with placebo at day three (<a href="./references#CD000219-bbs2-0058" title="RoversMM , GlasziouP , AppelmanCL , BurkeP , McCormickDP , DamoiseauxRA , et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet2006;368:1429-35.">Rovers 2006</a>). </p> <p>A previous meta‐analysis has examined whether antibiotics were indicated for AOM in children and concluded that the answer is a qualified 'yes' (<a href="./references#CD000219-bbs2-0056" title="RosenfeldRM , VertreesJE , CarrJ , CipolleRJ , UdenDL , GiebinkGS , et al. Clinical efficacy of antimicrobial drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials. Journal of Pediatrics1994;124:355-67.">Rosenfeld 1994</a>). It estimated a NNTB of seven for "primary control" (complete clinical resolution), compared with our NNTB of 20 for symptom relief. The difference may be the consequence of our focus on patient‐oriented outcomes, such as pain, rather than clinical signs, such as eardrum appearance. The previous systematic review suggests that where mastoiditis is not a concern, primary care physicians could weigh the benefits against the risks of adverse effects from antibiotics with their patients. This statement is in agreement with the findings of our review as adverse events such as diarrhoea, vomiting or rash were more common in children receiving antibiotics. In the IPD meta‐analysis, the most commonly described adverse effect of antibiotic treatment was diarrhoea, ranging from 2% to 14% in controls and from 4% to 21% in those given antibiotics (<a href="./references#CD000219-bbs2-0058" title="RoversMM , GlasziouP , AppelmanCL , BurkeP , McCormickDP , DamoiseauxRA , et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet2006;368:1429-35.">Rovers 2006</a>). Occurrence of rash ranged from 2% to 6% in the control groups and from 1% to 8% in the antibiotic groups. A recent systematic review and meta‐analysis on common harms of amoxicillin revealed that harms were poorly reported in most placebo‐controlled trials (<a href="./references#CD000219-bbs2-0044" title="GilliesM , RanakusumaA , HoffmannT , ThorningS , McGuireT , GlasziouP , et al. Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication. Canadian Medical Association Journal 2014 Nov 17 [Epub ahead of print]. [DOI: 10.1503/cmaj.140848]">Gillies 2014</a>). In this review, diarrhoea was attributed to amoxicillin only in the form of amoxicillin/clavulanate. Amoxicillin did increase the risk of candidiasis compared with placebo, but no association between amoxicillin and rash or vomiting was observed (<a href="./references#CD000219-bbs2-0044" title="GilliesM , RanakusumaA , HoffmannT , ThorningS , McGuireT , GlasziouP , et al. Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication. Canadian Medical Association Journal 2014 Nov 17 [Epub ahead of print]. [DOI: 10.1503/cmaj.140848]">Gillies 2014</a>). Bacterial resistance to antibiotics is also a consideration, with an association between antibiotic use and resistant bacteria demonstrated for many important pathogens (<a href="./references#CD000219-bbs2-0034" title="ArnoldSR , StrausSE . Interventions to improve antibiotic prescribing in ambulatory care. Cochrane Database of Systematic Reviews2005, Issue 4. Art. No: CD003539. [DOI: 10.1002/14651858.CD003539]">Arnold 2005</a>). </p> <p>Several trials evaluated a management strategy for AOM in which an expectant observational approach is used (<a href="./references#CD000219-bbs2-0008" title="LaxdalOE , MeridaJ , JonesRHT . Treatment of acute otitis media: a controlled study of 142 children. Canadian Medical Association Journal1970;102(3):263-8. ">Laxdal 1970</a>; <a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>; <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). In one of these trials, pain and malaise at day three were greater amongst those randomised to receive an antibiotic prescription with advice to fill it only if there was no improvement after 72 hours compared with those receiving immediate antibiotics (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>). In a secondary analysis of the trial, no difference was found between delayed and immediate treatment groups in ear function and ear pain at three and 12 months (<a href="./references#CD000219-bbs2-0053" title="LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practice2006;56:176-82.">Little 2006</a>). Another study using a similar prescribing approach and examining clinical outcomes at four to six days found no difference between immediate and delayed antibiotic groups (<a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>). In the third study (<a href="./references#CD000219-bbs2-0011" title="McCormickDP , ChonmaitreeT , PittmanC , SaeedK , FriedmanNR , UchidaT , et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics2005;115(6):1455-65. ">McCormick 2005</a>), immediate antibiotic treatment was associated with decreased numbers of treatment failures and improved symptom control at day four and day 12 compared with those allocated to expectant observation with no prescription. <a href="./references#CD000219-bbs2-0013" title="NeumarkT , MolstadS , RosenC , PerssonL , TorngrenA , BrudinL , et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16. Scandinavian Journal of Primary Health Care2007;25:166-71. ">Neumark 2007</a>, in a similar comparison, found that immediate antibiotics provided some symptomatic benefit; children who received antibiotics had less pain, used fewer analgesics and consulted less during the first seven days. Meta‐analysis of data from these four trials found no difference in pain between immediate antibiotics and expectant observational approaches at three to seven days. Another review (<a href="./references#CD000219-bbs2-0061" title="SpurlingGKP , Del MarCB , DooleyL , FoxleeR , FarleyR . Delayed antibiotics for respiratory infections. Cochrane Database of Systematic Reviews2013, Issue 4. Art. No: CD004417. [DOI: 10.1002/14651858.CD004417.pub4]">Spurling 2013</a>), which evaluated the effect of delayed versus immediate or no antibiotics for respiratory infections and which included two studies on AOM (<a href="./references#CD000219-bbs2-0010" title="LittleP , GouldC , WilliamsonI , MooreM , WarnerG , DunleaveyJ . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ2001;322:336-42. LittleP , MooreM , WarnerG , DunleavyJ , WilliamsonI . Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practitioners2006;56(524):176-82. ">Little 2001</a>; <a href="./references#CD000219-bbs2-0015" title="SpiroDM , TayK , ArnoldDH , DziuraJ , BakerM , ShapiroED . Wait-and-see prescription for the treatment of acute otitis media. JAMA2006;296(10):1235-41. ">Spiro 2006</a>), concluded that immediate antibiotics was the strategy most likely to provide the best clinical outcomes for AOM. One randomised study found that observation therapy with or without a prescription in children with AOM was well accepted by parents (<a href="./references#CD000219-bbs2-0040" title="ChaoJH , KunkovS , ReyesLB , LichtenS , CrainEF . Comparison of two approaches to observation therapy for acute otitis media in the emergency department. Pediatrics2008;121:31352-e6.">Chao 2008</a>). Antibiotic use was less in those randomised to observation without prescription and no complications were reported. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000219-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000219-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000219-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-FIG-03" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD000219-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Antibiotic versus placebo, outcome: 1.1 Pain." data-id="CD000219-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus placebo, outcome: 1.1 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-FIG-05" target="_blank"><b></b></a></p> </div><img alt="L'Abbé plot of the rates of pain at 24 hours for the placebo (control) versus antibiotic (experimental) group." data-id="CD000219-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-05.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>L'Abbé plot of the rates of pain at 24 hours for the placebo (control) versus antibiotic (experimental) group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-05.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-FIG-06" target="_blank"><b></b></a></p> </div><img alt="L'Abbé plot of the rates of pain at two to three days for the placebo (control) versus antibiotic (experimental) group." data-id="CD000219-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-06.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>L'Abbé plot of the rates of pain at two to three days for the placebo (control) versus antibiotic (experimental) group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-FIG-06.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Antibiotics versus placebo, Outcome 1: Pain" data-id="CD000219-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Antibiotics versus placebo, Outcome 1: Pain</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Antibiotics versus placebo, Outcome 2: Vomiting, diarrhoea or rash" data-id="CD000219-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Antibiotics versus placebo, Outcome 2: Vomiting, diarrhoea or rash</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Antibiotics versus placebo, Outcome 3: Abnormal tympanometry" data-id="CD000219-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Antibiotics versus placebo, Outcome 3: Abnormal tympanometry</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Antibiotics versus placebo, Outcome 4: Tympanic membrane perforation" data-id="CD000219-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Antibiotics versus placebo, Outcome 4: Tympanic membrane perforation</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Antibiotics versus placebo, Outcome 5: Contralateral otitis (in unilateral cases)" data-id="CD000219-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Antibiotics versus placebo, Outcome 5: Contralateral otitis (in unilateral cases) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Antibiotics versus placebo, Outcome 6: Late AOM recurrences" data-id="CD000219-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Antibiotics versus placebo, Outcome 6: Late AOM recurrences</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Immediate antibiotics versus expectant observation, Outcome 1: Pain" data-id="CD000219-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Immediate antibiotics versus expectant observation, Outcome 1: Pain</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Immediate antibiotics versus expectant observation, Outcome 2: Vomiting, diarrhoea or rash" data-id="CD000219-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Immediate antibiotics versus expectant observation, Outcome 2: Vomiting, diarrhoea or rash </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Immediate antibiotics versus expectant observation, Outcome 3: Abnormal tympanometry at 4 weeks" data-id="CD000219-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Immediate antibiotics versus expectant observation, Outcome 3: Abnormal tympanometry at 4 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Immediate antibiotics versus expectant observation, Outcome 4: Tympanic membrane perforation" data-id="CD000219-fig-0016" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Immediate antibiotics versus expectant observation, Outcome 4: Tympanic membrane perforation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000219-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/urn:x-wiley:14651858:media:CD000219:CD000219-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Immediate antibiotics versus expectant observation, Outcome 5: AOM recurrences" data-id="CD000219-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_t/tCD000219-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Immediate antibiotics versus expectant observation, Outcome 5: AOM recurrences</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/media/CDSR/CD000219/image_n/nCD000219-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000219-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Antibiotics versus placebo for acute otitis media in children</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Antibiotics versus placebo for acute otitis media in children</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> children with acute otitis media<br/><b>Settings:</b> primary care and secondary care<br/><b>Intervention:</b> antibiotics versus placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Antibiotics versus placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ pain at 24 hours</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>426 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>379 per 1000</b><br/>(332 to 431) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.89</b> <br/>(0.78 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1394<br/>(5 studies)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ pain at 2 to 3 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>159 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>113 per 1000</b><br/>(92 to 140) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.71</b> <br/>(0.58 to 0.88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2320<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ pain at 4 to 7 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>248 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>189 per 1000</b><br/>(124 to 283) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.76</b> <br/>(0.50 to 1.14) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1264<br/>(7 studies)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ pain at 10 to 12 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>216 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1000</b><br/>(37 to 142) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.33</b> <br/>(0.17 to 0.66) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>278<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vomiting, diarrhoea or rash</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>196 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>270 per 1000</b><br/>(227 to 319) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.38</b> <br/>(1.16 to 1.63) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2107<br/>(8 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Abnormal tympanometry ‐ 2 to 4 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>481 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>399 per 1000</b><br/>(347 to 462) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> <br/>(0.72 to 0.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2138<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Abnormal tympanometry ‐ 3 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>241 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>227 per 1000</b><br/>(159 to 323) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> <br/>(0.66 to 1.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>809<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> for ‘Study population’ was the average risk in the control groups (i.e. total number of participants with events divided by total number of participants included in the meta‐analysis). The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The number of studies reported in the summary of findings table for the outcomes 'Pain at 24 hours' and 'Pain at 4 to 7 days' differs slightly from those reported in the Data and Analysis Table 1 ‐ Antibiotics versus placebo (five versus six studies and seven versus eight studies, respectively). This is due to the van Buchem trial. This trial is included as one study in our review (and in the summary of findings table), but we included data from two different comparisons from this 2 x 2 factorial design trial (<a href="./references#CD000219-bbs2-0019" title="vanBuchemFL , DunkJHM , van't HofMA . Therapy of acute otitis media: myringotomy, antibiotics or neither? A double-blind study in children. Lancet1981;2:883-7. ">van Buchem 1981</a>) in our analyses.<br/><sup>b</sup>We downgraded the evidence for pain at days 10 to 12 from high certainty due to inconsistency. Only one trial reported this outcome and the outcome was not specified a priori. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Antibiotics versus placebo for acute otitis media in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000219-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Immediate antibiotics versus expectant observation for acute otitis media in children</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Immediate antibiotics versus expectant observation for acute otitis media in children</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> children with acute otitis media<br/><b>Settings:</b> primary care and secondary care<br/><b>Intervention:</b> immediate antibiotics versus expectant observation </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Antibiotics versus expectant observation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ Pain at 2 to 3 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>284 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b><br/>(99 to 224) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.53</b><br/>(0.35 to 0.79) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ Pain at 3 to 7 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>356 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>267 per 1000</b><br/>(178 to 398) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.75</b><br/>(0.50 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>959<br/>(4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain ‐ Pain at 11 to 14 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>669 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>609 per 1000</b><br/>(502 to 736) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b><br/>(0.75 to 1.10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>247<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vomiting, diarrhoea or rash</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>114 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>214 per 1000</b><br/>(159 to 287) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.87</b><br/>(1.39 to 2.51) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>946<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Abnormal tympanometry at 4 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>495 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>510 per 1000</b><br/>(386 to 668) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.03</b><br/>(0.78 to 1.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>207<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> for ‘Study population’ was the average risk in the control groups (i.e. total number of participants with events divided by total number of participants included in the meta‐analysis). The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High‐certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate‐certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low‐certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low‐certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the evidence for pain at two to three days from high certainty due study limitations (risk of detection bias) and imprecision (outcome data derived from one trial).<br/><sup>b</sup>We downgraded the evidence for pain at three to seven days from high certainty due study limitations (risk of detection bias).<br/><sup>c</sup>We downgraded the evidence for pain at days 11 to 14 from high certainty due study limitations (risk of detection bias) and because of the number of children that were 'lost to follow‐up' (13%), which introduced a risk of (attrition) bias.<br/><sup>d</sup>We downgraded the evidence for abnormal tympanometry findings at four weeks from high certainty as the number of children that were 'lost to follow‐up' in the immediate antibiotics group was substantially lower than in the expectant observation group (4% versus 11%), thereby introducing a risk of (attrition) bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Immediate antibiotics versus expectant observation for acute otitis media in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/full#CD000219-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000219-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotics versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Pain at 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.78, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Pain at 2 to 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.58, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Pain at 4 to 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.50, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 Pain at 10 to 12 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.17, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Vomiting, diarrhoea or rash <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [1.16, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Abnormal tympanometry <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 2 to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.72, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>953</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.70, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>809</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.66, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Tympanic membrane perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1075</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.21, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Contralateral otitis (in unilateral cases) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>906</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.25, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Late AOM recurrences <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.79, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotics versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000219-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Immediate antibiotics versus expectant observation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Pain at 2 to 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.35, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Pain at 3 to 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>959</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.50, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Pain at 11 to 14 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.75, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Vomiting, diarrhoea or rash <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>946</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [1.39, 2.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Abnormal tympanometry at 4 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.78, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Tympanic membrane perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [0.20, 24.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 AOM recurrences <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.77, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Immediate antibiotics versus expectant observation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000219.pub5/references#CD000219-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000219.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD000219-note-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD000219-note-0013">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000219-note-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000219-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD000219-note-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="id#CD000219-note-0018">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ko#CD000219-note-0008">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD000219-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="nl#CD000219-note-0020">Nederlands</a> </li> <li class="section-language"> <a class="" href="pl#CD000219-note-0019">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD000219-note-0009">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD000219-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD000219-note-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000219-note-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD000219-note-0015">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000219\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000219\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000219\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000219\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000219\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000219.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000219.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000219.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000219.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000219.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714485512"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000219.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714485516"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000219.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6fd6ec839377',t:'MTc0MDcxNDQ4NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 